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Abstract 
The Role of Flavors in Electronic Cigarette Abuse Liability in Tobacco-Naïve Young Adults 
Ilana Haliwa 
A primary public health concern associated with the use of electronic cigarettes (ECIGS) has 
been the risk of product initiation by vulnerable young adults who are largely naïve to tobacco. 
The use of ECIGs among such individuals may be influenced by the wide variety of sweet 
flavored liquids available for purchase. Previous work suggests that one flavor, menthol, 
increases the likelihood of abuse of cigarettes. Thus, the United States Food and Drug 
Administration has requested input from the research community regarding the abuse liability of 
flavored ECIGs in order to inform future product regulation. Using a double-blind, within-
subject study design, 30 young adults (aged 18-24 years, M = 19.43, 63.3% female, 83.3% 
Caucasian) who are largely tobacco-naïve experienced two sessions that differed by the flavor of 
ECIG liquid used: tobacco or fruit (choice of fruit medley or mango). Within each session, 
participants used the flavor assigned ECIG during two separate puffing bouts and rated product 
effects via subjective questionnaires (e.g., nicotine delivery, product acceptability) pre- and post-
bouts. Participants also rated subjective product appeal and engaged in both a progressive ratio 
and probability-based purchase task to assess willingness to work for and spend money on each 
flavor of ECIG. Smoking topography (i.e., puff number, duration, and inter-puff interval) was 
also analyzed.  Heart rate and subjective measures of nicotine delivery (e.g., lightheadedness, 
nausea, headache) were significantly higher post- bout compared to pre-bout, indicating nicotine 
delivery during puffing bouts. However,  few significant effects of flavor emerged across 
subjective, physiological, behavioral economic, or puffing topography outcomes.  Recruited 
participants had very low levels of lifetime ECIG use (M = 12.37 uses; range = 3 - 50 uses) and 
   
reported not enjoying ECIG use. Rather, the majority of participants reported social motivations 
as a primary reason for product use. While this study is the first to experimentally assess abuse 
liability of flavor among a sample of tobacco naïve young adults, results suggest that there may 
be factors other than flavor which motivate initial product use and susceptibility among naïve 
users with low lifetime use. 
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The Role of Flavors in Electronic Cigarette Abuse Liability in Tobacco-Naïve Young Adults 
As of June 22nd, 2009, the Food and Drug Association (FDA) has been granted authority 
to regulate tobacco products in the United States (U.S.) (H.R. 1256, 2009). Tobacco products 
subject to regulation under this law currently include cigarettes, cigarette tobacco, chewing 
tobacco, roll-your-own-tobacco, and smokeless tobacco. On August 8th, 2016, the FDA 
announced an extension of its regulatory authority to products such as hookah, pipe tobacco, 
cigars, and electronic cigarettes (ECIGs) (Food and Drug Administration Deeming Tobacco 
Products to be Subject to the Federal Food, Drug, and Cosmetic Act, 2016). These changes come 
on the heels of recent national survey findings, which demonstrate a jump in past month ECIG 
use among high school students from 1.5% in 2011 to 20.8% in 2018 (Cullen et al., 2018). 
Further, there was a 78% increase in current ECIG use among high school students just between 
2017 and 2018 (Cullen et al., 2018). In fact, data from the 2018 National Youth Tobacco Survey 
(NYTS) show that ECIGs are the most commonly used tobacco product among U.S. middle and 
high school students (Gentzke et al., 2019). ECIG use has also increased among young adults 
aged 18-24, with a 46.2% increase in current use between 2017 and 2018 alone (Dai & 
Leventhal, 2019). Among young-adult never-users of combustible cigarettes, a corresponding 
increase of 43.75% in current ECIG use was found (Dai & Leventhal, 2019). Fortunately, current 
FDA regulations include prohibition of sales to minors, free samples to consumers, and vending 
machine sales, as well as the requirement of labels that warn of the addictive nature of nicotine 
(Food and Drug Administration Deeming Tobacco Products to be Subject to the Federal Food, 
Drug, and Cosmetic Act, 2016). Still, ECIGs remain available to young adult consumers, 
including those who are naïve to nicotine. The FDA has thus called for input from the scientific 
community regarding the regulation of these novel devices (FDA, 2017).  
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ECIG Characteristics 
“ECIG” is a term used to describe an electronic nicotine delivery system which uses a 
liquid that typically contains nicotine, propylene glycol, vegetable glycerin, and flavoring. These 
devices consist of a storage component (e.g., a tank or a cartridge) to house the liquid, as well as 
a battery, heating element (e.g., resistance wire coil), and flow sensor (Brown & Cheng, 2014).  
The battery powers the heating element, which heats the liquid into an aerosol to be inhaled by 
the user (FDA, 2018). ECIG devices have been categorized by the research community into one 
of three generations (see Farsalinos & Polosa, 2014 for pictures). First-generation ECIGS are 
called “cig-alikes” because they are similar in design to combustible cigarettes, with 
mouthpieces and LED lights mimicking the filter and burning end of a cigarette rod, 
respectively. They often come with pre-filled cartridges containing the liquid solution (Cassidy, 
2011; Etter 2012). Second-generation ECIGs utilize refillable tanks or cartomizers to hold the 
liquid, and their batteries are typically capable of reaching higher voltages than first generation 
devices (Farsalinos et al., 2014). Finally, third-generation ECIGs (also known as “mods” or 
“variable voltage devices”) allow the user more control over certain features. For instance, the 
battery may be replaced, and the voltage output can be increased or decreased to the users’ 
desired setting (Wagener et al., 2017). Some of these devices, often called “pod-mods,” feature 
refillable or non-refillable pods containing ECIG liquid, paired with a battery. These various 
device features, in combination with features of the liquid, determine the level of nicotine 
delivered to the user.  
One device feature demonstrated to affect nicotine delivery is battery power, measured in 
volts (V). Higher battery power results in higher temperatures for aerosolizing the liquid solution 
(Trehy et al., 2011). Consequently, both cig-alikes (Talih et al., 2015) and tank models 
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(Kosmider et al., 2014) with battery power of 5.2 V have been shown to yield higher levels of 
nicotine compared to those of 3.3V. This fact may also explain why second-generation devices, 
which typically include a higher-powered battery, deliver nicotine more effectively than first-
generation devices (Farsalinos et al., 2014). Another ECIG feature that may influence nicotine 
yield is the ratio of the humectants, which are used in ECIG liquid for vapor production. The 
most commonly used humectants are propylene glycol (PG) and vegetable glycerin (VG), and 
liquids with a higher ratio of PG relative to VG have been shown to deliver higher levels of 
nicotine (Kosmider et al., 2014; Spindle & Eissenberg 2018). Of course, a higher concentration 
of nicotine in the liquid is directly related to higher nicotine delivery (Hiler et al., 2017). Finally, 
preliminary evidence suggests that the flavor of the liquid used may affect nicotine delivery (St. 
Helen, 2018). This topic has been understudied relative to those ECIG characteristics described 
above; however, the impact of flavor on nicotine delivery has been shown for other tobacco 
products. The history behind the use of flavor in such products is described below, followed by 
the application of this knowledge to understanding similar effects in ECIGs. 
The History of Flavorings in Tobacco Products  
 The tobacco industry has long used flavoring in existing tobacco products to increase 
their appeal and acceptability to consumers. For cigarettes, those flavored with menthol have 
been available since 1927 (Gardiner, 2003). Today, mentholated cigarettes represent 26% of the 
market share of all cigarettes sold in the U.S. (Federal Trade Commission, 2017), and recent 
national-level survey data suggest that 40% of current smokers use menthol cigarettes (Cohn et 
al., 2018). In addition to menthol, a variety of flavors are used in non-cigarette tobacco products. 
Smokeless tobacco products, for instance, have been sold in mint, wintergreen, champagne, and 
a variety of fruit flavors (cherry, apple, peach) (Kostygina & Ling, 2016; Tobacco Institute, n.d.). 
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Waterpipes (also known as hookah, shisha, or narghile; Maziak et al., 2015) are used with a 
sweetened tobacco called maassel, and the most popular choice of flavor is that of fruit (e.g., 
double apple, strawberry, mango) (Rose et al., 2018).  Hookah and smokeless tobacco are among 
the most prevalent flavored products used by youth (aged 12-17 years), young adults (aged 18-24 
years), and adults (25+). For those among these age groups who used these products in the past 
30 days, prevalence of flavored product use was 62%, 57.2% and 48.2%, respectively for 
flavored smokeless tobacco, and 71.5%, 68%, and 62.2%, respectively for flavored hookah 
(Rose et al., 2018). Cigars and cigarillos products, with flavors such as wine and vanilla, are also 
popular among users (Kostygina, Glantz, & Ling, 2014). Between 2014 and 2015, prevalence of 
flavored cigarillo-use among youth (12-17), young adults (18-24), and adults (>25) who had 
used the product in the past 30 days was 52.3%, 51% and 51.1%, respectively (Rose et al., 2018). 
Similarly, use of flavored cigars among young adults and adults who used the product in the past 
30 days was 47.2% and 50.2%, respectively (data not reported for youth aged 12-17; Rose et al., 
2018). The proliferation of flavors available for these non-cigarette tobacco products has been 
controversial, as tobacco companies have capitalized on flavor properties to market directly to a 
previously untapped demographic – tobacco-naïve youth (Carpenter et al., 2009; Kostygina & 
Ling, 2016).  
Marketing flavored tobacco products to tobacco-naïve youth serves the ultimate purpose 
of attracting a new generation of tobacco users. Flavoring can promote tobacco use through one 
of several different mechanisms, such as reduction of the initial aversive effects of tobacco use, 
serving as a reinforcing sensory cue when repeatedly paired with nicotine, and increasing the 
bioavailability of nicotine (Wickham, 2015). As for the first mechanism, the addition of 
flavoring is thought to improve taste by masking the harshness and bitterness of tobacco 
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(Carpenter et al., 2005; Cummings et al., 2002). Some flavors, such as menthol, may also soothe 
irritated airways during inhalation (Kreslake et al., 2010; Wickham, 2015; Wickham et al., 
2017). In line with this idea, among individuals who initiated tobacco use in the past 30 days, 
70% of youth (aged 12-17 years), 55% of young adults (aged 18-24 years), and 40% of adults 
(aged > 25) did so with a flavored product (Rose et al., 2018). Youth and young adults have also 
reliably rated flavored tobacco products more appealing than unflavored products (Ambrose et 
al., 2015; Krishnan-Sarin et al., 2015; McDonald & Ling, 2015). The second mechanism through 
which flavors may promote tobacco use is that of conditioning, with the flavor becoming 
associated with nicotine reinforcement as the two are repeatedly administered together 
(Wickham, 2015). Secondary reinforcers are particularly powerful in maintaining smoking 
behavior, as nicotine has shown to act as a reinforcement enhancer when paired with external 
cues (Chaudhri et al., 2006). For instance, smokers of mentholated cigarettes rate smoking as less 
rewarding when the menthol cue is removed (Rose & Behm, 2004). These same smokers were 
observed to be more resistant to extinction of reward responses to mentholated cigarettes than 
non-mentholated cigarette smokers were to their usual non-mentholated cigarettes (Rose & 
Behm, 2004). The third mechanism involves the influence of menthol on the bioavailability of 
nicotine in tobacco products. Specifically, menthol decreases elimination of nicotine in the body 
through inhibition of metabolic enzymes, thereby increasing the amount of nicotine in the 
bloodstream relative to smoking cigarettes without menthol (Benowitz, Herrera & Jacob, 2004; 
Perez-Stable & Benowitz, 2011). These and other potential mechanisms are described in detail 
elsewhere (Wickham, 2015).  
Notably, the tobacco industry has been aware of these mechanisms for years and has used 
this understanding to facilitate product initiation (Kostygina & Ling, 2016). Internal company 
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documents outline a “graduation strategy,” for example, for those naïve to smokeless tobacco 
(Connolly, 1995). Such individuals were deemed likely to begin use of smokeless tobacco with 
products relatively low in nicotine concentration but high in flavor content (U.S. Smokeless 
Tobacco Company, 1987). Indeed, “starter” smokeless tobacco products were developed to 
encourage initiation of smokeless tobacco use (Carpenter et al., 2009), with users expected to 
graduate from milder to more full-bodied products with relatively high nicotine concentration 
and less flavoring (Kostygina & Ling, 2016; U.S Smokeless Tobacco Company, 1987). Other 
companies used similar strategies for cigarettes, perhaps based on internal studies conducted 
with consumers. These studies found that cigarettes with sweet flavors were more appealing to 
tobacco users who were younger and less experienced (Brown & Williamson, 1984; Philip 
Morris, 1992; R.J. Reynolds, 1988). Subsequent years saw an increase in the number of brands 
that were sold in a variety of flavors, including KOOL Midnight Berry, Camel Twista Lime, and 
Camel Mandarin Mint (Carpenter et al., 2005). Today, all flavors (except for menthol) in 
cigarettes are prohibited by the 2009 Family Smoking and Tobacco Prevention Act. Flavored 
ECIGs are in the early stages of regulation by the FDA. As such, no formal regulations have 
been implemented at the national level. At the state level, only New York, Massachusetts, Rhode 
Island, and Washington have enacted legislation regulating the sale of ECIGs (National 
Conference of State Legislatures, 2019).  While all four states prohibit the sale of flavored 
nicotine and/or vaping products, Massachusetts has implemented the strictest legislation yet, 
banning the sale of any vaping products regardless of flavor (National Conference of State 
Legislatures, 2019).  
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Flavorings in ECIG Products 
In the majority of U.S. states, ECIG liquids are available in many flavor varieties, with 
one report demonstrating the existence of over 7700 different options: fruit (e.g., strawberry, 
mango, banana), dessert (e.g., banana split, caramel, chocolate), candy (e.g., cotton candy, 
skittles, gummy worms), alcohol/drinks (e.g., red bull, mojito, piña colada) flavors, among others 
(Zhu et al., 2014). Those flavors that simulate fruit tastes are most popular. In a review of ECIG 
flavor-related content via a web-based social networking forum (Reddit), researchers found that 
fruit flavors (n=15,720) were mentioned most frequently followed by cream (n=10,289), tobacco 
(n=7,475), menthol (n=3,421), and others (n’s < 3,347) (Wang et al., 2015). Of those posts that 
mentioned fruit flavors specifically, strawberry was the most popular (3,657 posts), with almost 
twice as many references as the second most popular flavor, banana (1,864 posts) (Wang et al., 
2015).  
Among the most common reasons for ECIG use among youth and young adults is the fact 
that they are available in a variety of appealing flavors (Tsai et al., 2018; Villanti et al., 2017). 
Nearly 61% of young adults aged 18-24 who have tried ECIGS report that their first use occurred 
with a flavored liquid (Villanti et al., 2017). Similar results emerged from the 2014-2015 
Population Assessment of Tobacco and Health Survey in which 81.6% of youth aged 12-17 and 
74% of young adults aged 18-24 who initiated ECIG use in the past year, reported doing so use 
with a flavored product (Rose et al., 2018). Additionally, fruit flavors are more likely to be tried 
by never-smoking adolescents than by current smokers attempting to quit (Ford et al., 2016). The 
appeal of flavors to younger individuals is further supported by experimental-based work; 
relative to adult smokers aged > 25 years, those aged 18-24 years were more likely to make 
hypothetical purchases of ECIGs when they were available in flavors (Pesko et al., 2016). These 
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and other findings suggest that “kid appealing flavors” (FDA, 2017) may be influencing the 
initiation and/or maintenance of ECIG use among certain populations. This idea has been 
examined systematically in only a few studies, as described below. 
 In one study (Walele et al., 2016), the nicotine delivery of a cig-alike ECIG product with 
and without menthol flavor (as well as an own brand of cigarette and a nicotine inhaler; results 
not discussed here) was examined in a sample of adult (mean age = 31.1 years) daily smokers 
with no previous ECIG experience. Within each condition, participants used their assigned 
product once per hour for four consecutive hours. Each puffing bout was standardized such that 
participants took 10 puffs every 30 seconds, and each puff was of 4-second duration. Blood 
samples were taken before and after each bout. No significant differences were observed 
between ECIG flavors in terms of nicotine absorption or elimination rates. A potential limitation 
of this study, however, is that the ECIG device used delivered negligible levels of nicotine to the 
user relative to a cigarette (i.e., maximum concentration of 2.5-3.6 ng/ml for the ECIG flavors 
vs. 21.2 ng/ml for the cigarette). Consequently, the range of possible plasma nicotine levels 
observed after ECIG use was restricted. 
Other work was designed to compare nicotine intake between ECIG flavors of tobacco, 
strawberry, and participants’ usual flavor (St. Helen et al., 2017; St. Helen et al., 2018). This 
within-subject study included 14 adult (mean age = 32.3 years) users of ECIGs, either 
exclusively (n=4 never smokers; n=12 former smokers) or concurrently with cigarettes (< 5 
cigarettes per day). Within each condition, participants engaged in a single 15-puff directed bout 
in addition to a 90-minute ad libitum bout. Relative to tobacco flavor, strawberry flavor resulted 
in significantly longer puffs from the ECIG, a higher (non-significant) maximum concentration 
of nicotine in plasma, and comparable subjective ratings of liking and enjoyment (St. Helen et 
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al., 2017; 2018). Also observed was that, relative to both strawberry and tobacco flavors, 
participants’ usual flavor resulted in significantly more and longer puffs from the ECIG, and 
significantly higher ratings of items that denote product acceptability (St. Helen et al., 2017; 
2018). The lack of a significant difference between flavors for the subjective ratings of product 
acceptability may be influenced by the participants’ previous ECIG use. That is, these 
experienced ECIG users (mean = 2.3 years of ECIG use) reported that their preferred flavors 
were largely those other than fruit: cream/honey/milk (n=3), drink (n=3), and more than one 
flavor (n=5) versus fruit/candy (n=3). 
In other experimental work, however, participants’ subjective experience of use has 
differed as a function of ECIG liquid flavor. One study included 31 adult (mean age = 33.6 
years) ECIG users, who either used ECIGS exclusively (daily use of a medium nicotine strength 
liquid for at least the past month) or dual users of ECIGS and cigarettes (daily cigarette smoking 
for at least the past year and ECIG use at least 3 days/week) (Kim et al., 2016). Participants were 
instructed to take 4 puffs from each of 6 commercially available flavors using a second-
generation device, and rated various subjective effects following each bout. All flavors were 
used within a single session, and a “palate cleansing” procedure was administered in between 
each use. Ratings of liking were correlated positively with ratings of sweetness and coolness (r’s 
=0.31 & 0.25, p’s < .001) and correlated negatively with ratings of bitterness and harshness (r’s 
= -0.25 & -0.29, p’s <.001). The tobacco flavored liquid was perceived as the least sweet and the 
least liked. Similar relationships between flavor properties and product appeal have been 
demonstrated in other studies of adult ECIG users. For instance, 20 adult (19-34 years) ECIG 
users (weekly ECIG use > 1 month) who smoked less than 15 cigarettes per day were recruited 
to self-administer 20 different ECIG solutions (10 flavors each at 0 and 6 mg/ml doses) from a 
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second-generation device (Goldenson et al., 2016). Sweet flavors resulted in significantly higher 
ratings of liking and willingness to use the product again, compared to non-sweet flavors. 
Participants also stated that they would be willing to pay a higher amount of money for a day’s 
worth of sweet flavored liquid than non-sweet flavored liquid (Goldenson et al., 2016). Together, 
these studies provide initial laboratory evidence for the role of flavors in ECIGS on product 
appeal among ECIG users. 
 In addition to using self-report measures, some researchers have made use of behavioral 
economics tasks to assess abuse liability of various ECIG flavors. The field of behavioral 
economics represents a fusion of psychology and economics, in which behavioral principles can 
be used to predict economic outcomes (e.g., willingness to purchase a particular item, the effects 
of a tax increase on purchasing behavior, the effects of a delay until the item is received). In a 
study of 32 daily cigarette smokers aged 18-30 (mean age = 25.0 years), with an average of 12.0 
(15.4) lifetime ECIG uses, participants self-administered three ECIG flavors (green apple, 
chocolate, and unflavored) from a second-generation device (Audrain-McGovern, Strasser & 
Wileyto, 2016). They then rated each flavor based on its subjective reward value and engaged in 
90-minute ad libitum bout with the option to use any flavor of their choice. Participants also 
completed a behavioral economics task, whereby they used a computer mouse to hit targets on 
one of two computer screens to earn points towards puffs from either a flavored or unflavored 
ECIG, with the option to switch between computers at will. Reinforcement for the unflavored 
ECIG was delivered on a fixed ratio schedule, with 25 target hits required to earn a point. 
Reinforcement for the flavored ECIG was delivered on a progressive ratio schedule, such that 
each successive point required 25 more target hits than the previous one. Willingness to put forth 
increasing levels of effort for access of a flavored ECIG serves as a measure of the reinforcement 
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value of flavored relative to unflavored ECIGs. Participants rated both the green apple and 
chocolate flavored ECIG as more rewarding and were willing to put forth significantly more 
effort to obtain these flavors (i.e., perform more target hits), relative to the unflavored ECIG. 
Additionally, participants took twice as many puffs of the flavored liquid (40.29 puffs) as the 
unflavored liquid (23.22 puffs) during ad libitum use. Thus, in regular cigarette smokers with 
little ECIG experience, these sweet flavors were preferred over unflavored liquid as evidenced 
by both subjective and behavioral outcomes. 
Behavioral economics tasks were also used to characterize the abuse liability and 
preference for flavored ECIG products in a two-part study of 36 adult (mean age = 37.8 years) 
daily cigarette smokers with limited ECIG use (i.e., > 1 weeks for > 1 month) (Barnes et al., 
2017). Participants were exposed to a second-generation ECIG flavored with either tobacco or 
menthol liquid (Study 1; n=17), or cherry or unflavored liquid (Study 2; n=19). They then 
engaged in tasks that measure the participants’ willingness to purchase products across various 
price points. No significant differences were observed for willingness to purchase tobacco vs. 
menthol liquid; however, participants were willing to pay significantly more for the cherry 
flavored liquid than the unflavored liquid. That no differences were observed between tobacco 
and menthol may be due to the fact that the majority of participants were smokers of menthol 
cigarettes, as the menthol flavor profile of ECIG liquid may not be comparable to that for 
cigarettes.  
Together, this work suggests that flavorings in liquid may contribute to the abuse liability 
of ECIG devices, at least among individuals who have a history of tobacco use. Little similar 
work exists in a population of vulnerable tobacco-naïve individuals. Thus, it remains unknown 
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whether flavors have the potential to promote the use of ECIGs among individuals who are not 
tolerant to the effects of nicotine and who have had little exposure to tobacco-related cues. 
Statement of the Problem 
Use of ECIGS by youth and young adults has skyrocketed in recent years, with a 16% 
prevalence of past 30-day use in middle and high school students in 2015, compared to 1.5% in 
2011 (USDHHS, 2016). In 2014, the prevalence of lifetime ECIG use and past 30-day use in 
young adults 18-24 years was 35.8% and 13.6%, respectively. These rates are significantly 
higher for young adults than for adults 25 years and older (16.4% and 5.7%, respectively; 
USDHHS, 2016). Youth and young adults prefer flavored ECIG products to unflavored products 
(Ambrose et al., 2015; Krishnan-Sarin et al., 2015; McDonald & Ling, 2015). In fact, among 
young adults who first tried within the past year, 74% did so with a flavored product (Rose et al., 
2018). Sale of flavored liquids may thus contribute to a continued rise in the prevalence of ECIG 
use, which has been shown to serve as a gateway for the use of combustible tobacco products 
(Leventhal et al., 2015; Primack et al., 2015; Wills et al., 2016).  Initiation and subsequent 
“graduation” of non-tobacco users from experimentation with flavored nicotine products to 
regular use has been a documented market strategy by the tobacco industry (David Weiss 
Associates, 1987). Laboratory research is needed to evaluate the role of flavors in likelihood of 
product initiation and abuse liability in tobacco-naïve young adults.  
Implications 
 In light of the aforementioned findings regarding risk for smoking initiation in non-
smoking youth, the proposed study has implications ranging from smoking prevention to 
national policy regulation. The FDA has appealed to the scientific community to provide data on 
which to base future policy and regulation of ECIG products, with a particular emphasis on 
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addressing the possibility of flavored ECIGS serving as a gateway product to regular 
tobacco/nicotine use. While abundant survey data highlights the role of flavor in the initiation of 
ECIG use by young adults, laboratory research such as this is needed to better characterize 
smoking behavior, reward value of flavored ECIG products, and the ability of flavor to mask the 
harshness of nicotine in this population.  
Method 
Selection of Participants 
A total of thirty largely tobacco-naive individuals completed this within-subject study. 
This sample size was calculated using G*power based on the power needed to detect the effects 
of primary interest (i.e., differences between flavors for subjective ratings of product 
acceptability and behavioral response via the behavioral economic tasks), assuming a small to 
medium effect size (Cohen’s f = 0.15-.20; Cohen, 1992), a moderate correlation among repeated 
measures (r = 0.50), a Type I error rate of 0.05, and a desired power of 0.80.   
Inclusion criteria 
Healthy volunteers between the ages of 18 to 24 were recruited via word-of-mouth, and 
advertisements (e.g., flyers, electronic announcements) approved by the Institutional Review 
Board. To ensure that participants were largely tobacco-naïve, they were required to report fewer 
than 100 lifetime uses of any tobacco products (as in Bondy et al., 2009; CDC, 2017; Jones, 
Gulbis & Baker, 2010; Ozga et al., 2016), as well as no tobacco use (excluding ECIGs) in the 
past 30 days.  For use of ECIGs specifically, they were required to report at least 3 lifetime uses 
and to never have used an ECIG containing nicotine on 7 consecutive days. Participant 
recruitment was stratified in order to include relatively equal amounts of naïve users with low 
ECIG use (< 10 lifetime uses) and those with relatively higher ECIG use (> 10 lifetime uses).  
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These criteria were chosen with the goal of enrolling participants who were relatively 
inexperienced but not entirely naïve to ECIGs. 
Exclusion criteria 
Individuals were excluded if they reported any uncontrolled medical or psychiatric 
conditions, use of any other illicit drug use in the past month, or current breast-feeding or 
pregnancy (confirmed via urinalysis). Also excluded were volunteers reporting use of marijuana 
on more than five days of the past month. Based on similar route of administration, regular use 
of marijuana could affect ECIG puff topography outcomes (Agrawal & Lynskey, 2008; Aung, 
Pickworth & Moolchan, 2004; Fielder, Carey & Carey, 2013). However, given the prevalence of 
marijuana use among young adults aged 18-24 (Lipari & Jean-Francois, 2016; NIDA, 2017), we 
chose to limit past marijuana use rather than excluding any use. In order to protect the privacy of 
individuals divulging use of an illegal substance, a Certificate of Confidentiality was obtained 
from the National Institute of Drug Abuse (https://humansubjects.nih.gov/coc/background). 
Similar exclusion criteria have been successfully implemented in past studies (Blank et al., 2009; 
Breland et al., 2002; Cobb et al., 2010; Eissenberg et al., 1996; Ozga et al., 2016; Spindle et al., 
2015). 
Pre-screening procedure 
Potential participants who responded to study advertisements first completed a pre-
screening interview (Appendix A) in which they responded to questions regarding basic 
demographic and medical history information, as well as past and current substance use, 
including nicotine, alcohol, and illicit substance use. Volunteers who were eligible based on the 
pre-screen were then asked to visit the laboratory for a detailed in-person screening. 
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Informed consent & in-person screening procedures.  
Individuals were guided through the informed consent form to convey the study purpose, 
study procedures, and the potential risks and benefits of participation. Those who were able and 
willing to consent completed additional screening questionnaires assessing information similar to 
that obtained during the telephone screening (Appendix B & C). This overlap in questionnaire 
items is intentional and allowed the researchers to ensure reliable reporting. Individuals whose 
responses were unreliable were excluded from further study participation. Nonsmoking status 
was confirmed with an expired air CO level of  < 5 ppm (SRNT, 2002), measured via breath 
sampling with a non-invasive monitor (piCO+ Smokerlyzer. coVita; Haddonfield, NJ), as well as 
with a urinary cotinine value < 100 ng/mL (NicAlert Nicotine Test. Jant Pharmacal Corporation; 
Encino, CA). Females were asked to provide a urine sample to allow for semi-quantitate testing 
of pregnancy. Finally, all participants were familiarized with the testing environment, 
questionnaires, and measurement equipment.  
Study Design 
This study used a within-subject design, with participants experiencing two conditions in 
random order that differ by the flavor of ECIG liquid administered: tobacco or fruit (choice 
between mango and fruit medley). Within each condition, participants used the flavor assigned 
ECIG during two separate puffing bouts, rated product effects via subjective questionnaires (e.g., 
nicotine delivery, product acceptability) pre- and post-bouts, and completed behavioral choice 
tasks (e.g., hypothetical purchase, progressive ratio). Following completion of the second 
session, participants completed a questionnaire assessing expectancies regarding the effects of 
ECIGs as well as the perceived risks of ECIGs relative to cigarette products (Appendices D & 
E), as well as a semi-structured exit interview (Appendix F). 
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Session procedure 
All study sessions took place on the Downtown Campus of West Virginia University. 
Sessions were separated by a minimum of 48 hours to avoid carryover effects (as in Breland et 
al., 2002; Eissenberg et al.,1996; Lechner et al., 2015; Spindle et al., 2015), and were preceded 
by 12 or more hours of nicotine/tobacco abstinence. As shown in Figure 1, expired air CO level 
was measured at the beginning of each session in order to verify abstinence (< 5ppm) from 
combustible products such tobacco and marijuana (Blank et al., 2009; Spindle et al., 2015a; 
Tackett et al., 2015). Participants were then connected to physiological equipment for continuous 
measurement of heart rate and blood pressure. Thirty minutes later, participants completed 
baseline questionnaires: Direct Effects of Nicotine Scale (DENS, Appendix G; Evans et al., 
2006) and Direct Effects of Product Scale (DEPS, Appendix H; Spindle et al., 2015a). Next, 
participants completed their first puffing bout, whereby they took one ECIG puff every 30 
seconds for a total of 10 ECIG puffs as guided by laboratory staff (as in Spindle et al., 2015a; 
Vansickel et al., 2010; Vansickel & Eissenberg, 2013). Directly after this bout, participants 
completed the DENS and the DEPS again. Thirty minutes after the first bout, participants 
experienced a second bout, identical to the first (subjective questionnaires, puffing bout, and 
subjective questionnaires). In between the two puffing bouts, participants completed a 
probabilistic purchase task. Forty-minutes after the end of the second puffing bout, participants 
engaged in a progressive ratio task. Following completion of the second study session, 
participants completed questionnaires assessing their understanding of and beliefs about ECIG 
products. Participants were compensated $25 per session, for a total of $50 for complying with 
all study requirements.  
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Materials 
ECIG devices and liquid. Participants used a JUUL ECIG (JUUL Labs; San Francisco, 
California). This brand of EC device has quickly become one of the most popular devices on the 
market and has been shown to be particularly appealing to young adults (Huang, Duan, Kwok, 
Binns,…Emery, 2018; Kavuluru, Han, and Hahn, 2018). Liquid for these devices come 
prepackaged in pods with 59 mg/ml nicotine and a ratio of 30:60 propylene glycol to vegetable 
glycerin. Liquid was either tobacco or fruit flavored and participants were given a choice 
between fruit medley and mango for the fruit condition. These flavors were chosen based on a 
combination of survey reports (Harrell et al., 2016; Rose et al., 2018; Shang et al., 2018), 
screening data from our ongoing laboratory work, as well as discussion with local retailers. 
Together, these sources suggest that fruit blends are a preferred flavor among ECIG users, 
including those who live within the greater Morgantown area. These sources also suggest that 
mango is a popular flavor, and thus would be an alternative choice for those who find the fruit 
blend flavor unappealing.  Importantly, recently presented data demonstrate that JUUL delivers 
physiologically active doses of nicotine (Maloney et al., 2019b).  
ECIG topography video scoring. Puff topography was measured via video recording 
(Vixia HF R700, Canon, Melville, NY). Puff onset was identified as the first video frame in 
which a user’s lips were enclosed around the ECIG mouthpiece, while puff offset was defined as 
the last frame in which a user’s lips were enclosed around the ECIG mouthpiece. Puff number 
was measured as the total number of discrete puffs (> 300 milliseconds) completed within a 
puffing bout. Puff duration was measured as the amount of time, in seconds, between the onset 
and offset of a single puff. Inter-puff interval also was measured in seconds and is the amount of 
times between the offset of one puff and the onset of a subsequent puff. All video-recorded data 
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were scored by two independent raters and then compared for reliability using a minimum cutoff 
of ICC > 0.90. Latency to puff for the PRT was recorded as the time between a participant 
earning a reward and puff onset. The participant’s screen is shown in the video, and thus scorers 
are able to see the exact time point at which a puff was earned. This method of topography 
measurement and scoring has been used successfully in prior work for cigarettes (Blank et al., 
2009; Frederiksen et al., 1977; Lichtenstein & Antonuccio, 1981) and for ECIGs (Felicione, 
2016). 
Primary Outcome Measures  
Direct Effects of Product Scale. The Direct Effects of Product Scale (Appendix H; 
Blank et al., 2011; Spindle et al., 2015a; Vansickel et al., 2010) contains nine VAS items 
assessing effects commonly reported with ECIG smoking (e.g. “Was the ECIG satisfying?” and 
“Did the ECIG help you concentrate?”). Scale ratings range from zero to 100, with each item 
scored separately. 
Progressive Ratio Task (PRT). A computerized progressive ratio task was used to 
assess ECIG self-administration (as in Copp et al, 2015; Barrett, 2010). Initially, ten key presses 
were required in order to earn the first puff of the ECIG. Subsequently, the number of key 
presses required to earn a puff increased by 30% after each puff. The outcomes for this task 
consist of break point (the maximum number of key presses to earn a puff), the number of self-
administered ECIG puffs, and the latency (in seconds) to initiate each puff.   
Probability-Based Purchase Task (PBPT). At each session, participants completed a 
probability-based version of the purchase task (Roma et al. 2015; Stein & Bickel, 2018), in 
which they reported the likelihood (on a scale from 1 – 100) that they would purchase an ECIG 
in the assigned flavor across a range of prices ($0, $0.13, $0.25, $0.50, $1, $2, $4, $8, $15, $30, 
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$60, $120, $240 per ECIG). Outcome measures derived from task completion include breakpoint 
(first price at which probability is zero), demand intensity (probability of purchase at zero), 
demand elasticity, and area under the curve (AUC). Demand elasticity was calculated using a 
modified exponential demand equation (Kofarnus, Franck, Stein & Bickel, 2015; Stein & Bickel, 
2018) and represents the sensitivity of demand to changes in price (the proportion of change in 
quantity demanded to change in price). Values of elasticity < 1 represent inelasticity of demand, 
where demand for a product changes little despite larger changes in price. Values > 1 represent 
elasticity of demand, where demand for a product is strongly influenced by changes in price such 
that demand may change greatly in response to small changes in price. Finally, a demand value 
equal to 1 indicates that changes in demand are perfectly proportional to changes in price. 
Demand for substances with high abuse potential are often inelastic, as demand for the substance 
remains high in spite of fluctuations in pricing (Greenwald, 2018). Finally, AUC was calculated 
by plotting the area under each participant’s demand curve and reflects overall consumption 
across prices (Amlung, Yurasek, McCarty, MacKillop & Murphy, 2015; Stein & Bickel, 2015). 
Higher AUC values represent greater overall probability of purchase.  
Secondary Outcome Measures  
Direct Effects of Nicotine Scale (DENS). The DENS (Appendix G; Evans et al, 2006) 
contains 10 VAS items addressing severity of nicotine-associated side effects: “nauseous,” 
“dizzy,” “lightheaded,” “nervous,” “sweaty,” “headache,” “excessive salivation,” “heart 
pounding,” “confused,” and “weak.” Scale ratings range from zero to 100, with each item scored 
separately. 
Puff topography. Puff topography was measured using video scoring. Outcomes consist 
of puff number, duration (measured in seconds), and IPI (measured in seconds). 
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Physiological measures. Heart rate and blood pressure were measured continuously 
throughout each session (Noninvasive Patient Monitor model 506 NP3, Criticare Systems, Inc., 
Waukesha, WI). Heart rate data and blood pressure were collected every 20 seconds and every 5 
minutes, respectively. Both serve as measures of exposure to nicotine (Jolma et al., 2002; 
Omvik, 1996) and also to verify participant safety. These materials for collecting physiological 
data have been used in similar work (Blank et al., 2009; Breland et al., 2002; Evans et al., 2006; 
Spindle et al., 2015a). 
Generalized Labeled Magnitude Scale (gLMS). Participants were asked to rate the 
perceived intensity of three sensations (flavor sensation, harshness/irritancy, and throat hit) on a 
100-point scale with seven labeled anchors (no sensation, barely detectable, weak, moderate, 
strong, very strong, strongest imaginable; Appendix I).  
ECIG Risk Perception. Following the second and final study session, participants 
answered a set of three questions on their beliefs about the risks of ECIG products (Appendix E). 
Each item uses a rating scale that ranges from strongly disagree to strongly agree (e.g. 
“Electronic cigarettes are less harmful than regular cigarettes”). These questions have been 
adapted from previous qualitative research on ECIG attitudes, beliefs, and opinions (Choi & 
Forster, 2014; Kotecha, Jawad & Lliffe, 2016; McQueen, Tower & Sumner, 2011).  Responses 
are scored from zero to three and then summed and reverse scored, resulting in a possible score 
range of zero to nine, with higher scores representing higher risk perception.  
ECIG Outcome Expectancy. Also administered at the end of the final session was the 
short form of the e-cigarette outcome expectancies measure (Appendix D; Pokhrel et al., 2018). 
This measure consists of eight items on which participants rate their perceived likelihood of 
experiencing certain outcomes if they were to use an ECIG (e.g.: “become more popular” or 
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“hurt your lungs”). Each item is presented on a nine-point Likert scale, with responses ranging 
from “unlikely” to “likely.” Each item corresponds to one of two factors: positive or negative 
outcome expectancies. Positive outcome expectancy variables (n=4) are positively and 
significantly associated with ECIG use susceptibility (as measured by intention and willingness 
to use ECIGS), while negative outcome expectancy variables (n=4) are inversely and 
significantly correlated with current ECIG use (Pokhrel et al., 2018). Items within each sub-scale 
(positive and negative) are summed, with possible results for each ranging from zero to 36.  
Flavor Discrimination. Following administration of the ECIG Risk Perception and 
Outcome Expectancy measures at the final session, participants were asked to identify at which 
session they believed they received a fruit flavored ECIG, and at which session they believed 
they received the tobacco flavored electronic cigarette (Appendix J).  
Exit Interview. At the end of the final session, participants were administered a semi-
structured interview consisting of nine questions regarding ECIG use history (e.g., typical 
environment during use, reasons for use) as well as four questions regarding their experience in 
the current research study (e.g., comparing ECIG use in the lab to naturalistic use; Appendix F).  
Participant Safety and Rights 
 Participants’ safety and rights were assured through an IRB-approved protocol enacted 
by trained laboratory staff. Participants were made aware of the Office of Research Integrity and 
Compliance, and their right to contact this office with any questions about their role as 
participants. No adverse events were expected for brief use of the ECIG device; however, 
individuals were informed of the potential risks (e.g., liquid ingredients that may serve as an 
allergen). Heart rate and blood pressure were monitored continuously throughout each session to 
ensure participant safety. A medical monitor was available for contact if a participant’s heart rate 
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fell out of the range of 50 to 110 bpm, systolic blood pressure out of the range of 90 to 150 
mmHg, or diastolic blood pressure out of the range of 60 to 100 mmHg.  Confidentiality was 
ensured through the use of coded identity numbers for participant data. Data was stored in locked 
rooms and on password protected computers.  
Data Analysis 
Values for heart rate and systolic and diastolic blood pressure were computed by 
averaging across the 5 minutes preceding and the 5 minutes following a directed bout in order to 
obtain pre- and post-bout values. Subjective questionnaire (i.e., DEPS and DENS) and 
physiological data were analyzed using 3-factor, repeated measures analyses of covariance 
(ANCOVAs): condition (two levels: tobacco and fruit flavor) x bout (two levels: bouts 1 and 2) x 
time (two levels: pre- and post-bout). Covariates included ECIG lifetime use (both subjective and 
physiological outcomes), as well as risk perceptions and expectancies (subjective outcomes 
only). These covariates were selected due to their potential for influencing select outcome 
variables. ECIG lifetime use may affect both subjective and physiological outcomes by 
influencing the length of ECIG puffs, as more experienced users tend to take longer puffs 
resulting in higher nicotine delivery (Farsalinos et al., 2015; Hiler et al., 2017). Further, among 
youth and young adults, greater ECIG use experience is associated with higher positive 
expectancies as well as lower negative expectancies and risk perception (Bernat et al., 2018; 
Chafee et al., 2015). In turn, ECIG risk perception and expectancies may influence participants’ 
willingness to engage with the ECIG device.  For example, individuals with higher risk 
perception and negative expectancies may be less willing to engage with the ECIG product 
(Leung et al., 2018) thus reducing the likelihood of engagement during  behavioral economics 
tasks.  
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Puff topography and gLMS data were also analyzed using repeated measures ANCOVAs, 
but without the time factor included (i.e., condition x bout). Note that gLMS data are based on 
n=17, as this measure was added to the protocol later in the data collection phase. These same 
analyses sans covariates were conducted using session order (1 and 2) instead of flavor (fruit and 
tobacco) for the condition factor to examine potential order effects. Finally, mixed repeated-
measures ANOVAs for all measures, including behavioral economic task outcomes, were 
conducted to examine differences due to fruit choice, flavor order, gender, and race, respectively. 
Given limited variability of race (n = 25 White, n = 5 non-White), the variable was 
dichotomized. Of 175 possible main and interaction effects involving each variable as a between-
subjects factor, 5 were significant for fruit choice, 9 for flavor order, 9 for gender, and 15 for 
race. Given the paucity of significant effects for fruit choice, flavor order, and gender (< 5%) and 
lack of consistent and meaningful patterns of significance, results for these analyses are not 
described further. For significant analyses, differences between means were examined using 
Tukey’s Honestly Significant Difference (HSD; p < .05). Descriptive statistics are provided for 
flavor discrimination, fruit choice, lifetime product use, ECIG risk perception, and EIG 
expectancy data. As with the gLMS, flavor-discrimination questions were only completed by 17 
participants given the delay in inclusion of the measure. All other measures include data from all 
30 participants. Finally, responses to the exit questionnaire were summarized.  
Study Hypotheses 
 Some study results were predicted based on previous research on similar topics. The 
hypotheses were as follows: For subjective items, fruit flavored liquid were hypothesized to be 
rated more pleasurable than tobacco flavored liquid as evidenced by higher ratings of items such 
as “taste good,” “satisfying,” and “liking” (as in Audrain-McGovern, Strasser & Wileyto, 2016; 
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Goldenson et al., 2016; Kim et al, 2016). For the behavioral economic tasks, participants were 
hypothesized to work harder (i.e., have higher break points on the progressive ratio task) for fruit 
flavored liquid as opposed to tobacco flavored liquid (as in Audrain-McGovern, Strasser & 
Wileyto, 2016), and to be significantly more likely to purchase fruit flavored liquid at higher 
prices than tobacco flavored liquid (i.e., will have higher crossover points on the probabilistic 
purchase task; as in Barnes et al., 2017; Goldenson et al., 2016). Secondary outcome measures 
were exploratory, and thus no formal hypotheses were proposed.  
Results 
Demographics 
 Of 41 total participants recruited, eight were excluded (n = 4 for inconsistent reporting at 
screening; n = 2 for expired air CO > 5 ppm;  n = 2 for urinary cotinine values > 100 ng/mL). 
Three participants dropped out of the study following enrollment, leaving a final sample of 30 
study completers. Participant baseline characteristics for these 30 participants are displayed in 
Table 1. Those young adults enrolled were largely college students, Caucasian, and female, with 
a range of 3 to 50 lifetime ECIG uses (median = 10; mode = 10). Their choice between fruit 
medley and mango flavors were relatively comparable.  
Primary Outcome Measures 
 For all primary and secondary subjective, physiological, and topography outcomes, 
results for repeated measures ANCOVAs are displayed in Table 2. Due to the large number of 
main and interaction effects adjusted for covariates, and the very few significant findings, results 
for factors by each covariate are not provided in table format. Rather, these results are described 
in the below text as relevant. Results for mixed repeated-measures ANOVAs that include race as 
a between-subjects factor are displayed in Table 3.  Repeated measures ANOVAs that describe 
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order effects are displayed in Table 4. Finally, mixed repeated measures ANOVAs for behavioral 
economics outcomes are included in Table 5. 
Direct Effects of Products Scale. As shown in Table 2, few main or interaction effects 
were observed for the DEPS items. A significant main effect of bout (i.e., collapsed across flavor 
and time factors) was detected for “pleasant,” such that participants rated the ECIG as 
significantly more pleasant at the second (M = 25.0, SE = 3.2) compared to the first (M = 13.5, 
SE = 1.7) puffing bout of each session, F(1, 25) = 4.31, p = .048, partial η2 = 0.15. For the items 
“taste good” and “calm,” a significant bout x time interaction was observed (F’s > 5.45, p’s < 
0.05, partial η2 > 0.18). These effects also were significant for the bout x time x risk interaction, 
F’s > 4.53, p’s < 0.05, partial η2 > 0.15. Mean “taste good” scores were 0.1 (SE = 0.06) and 33.5 
(SE = 4.7) at pre- and post-bout 1, respectively, and 23.3 (SE = 4.6) and 32.9 (SE = 4.9) at pre- 
and post-bout 2, respectively. Scores were significantly different between pre- and post-bout for 
bout 1 but not bout 2, as were scores between pre-bouts 1 and 2 (Tukey’s HSD, p < 0.05). A 
similar pattern was observed for “calm,” where mean scores were 0.12 (SE = 0.05) and 24.98 (SE 
= 3.3) at pre- and post-bout 1, respectively, and 18.2 (SE = 3.9) and 23.8 (SE = 3.8) at pre- and 
post- bout 2, respectively (Tukey’s HSD, p < 0.05). 
When examining effects as a function of race (Table 3), a bout x race interaction was 
revealed for “sick” ratings, F(1, 28) = 7.47, p = .011, partial η2 = 0.21, where significant 
increases in sickness were reported between bout 1 and bout 2 for non-White (M = 14.0, SE = 
4.5, and M = 35.6, SE = 8.9, respectively; Tukey’s HSD, p < .05), but not White participants (M 
= 7.6, SE = 1.99, and M = 11.1, SE = 3.96, respectively; Tukey’s HSD, p > .05). Further, “sick” 
ratings at bout 2 were significantly higher for non-White participants than White participants 
(Tukey’s HSD, p < .05). For “dizzy,” there was a bout x time x race interaction, F(1, 28) = 4.84, 
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p =.036, partial η2 = 0.15 (see Figure 2). For both White and non-White individuals, ratings 
increased significantly in bout 1 (Tukey’s HSD, p < 0.05) but not bout 2 (Tukey’s HSD p > .05). 
Further, post-bout 2 ratings for non-White participants were significantly higher than either post-
bout rating for White participants (Tukey’s HSD, p < .05). Finally, a flavor x bout x time x race 
interaction was present for “pleasant,” F(1, 28) = 6.12, p =.020, partial η2 = 0.18 (see Figure 3). 
For White individuals, ratings of “pleasant” increased significantly from pre- to post-bouts 1 and 
2 within each flavor (Tukey’s HSD, p < 0.05). For non-White individuals, the fruit flavored 
ECIG produced increases from pre-to post- bout that were significant for bout 1 (Tukey’s HSD, 
p < .05), but not bout 2 (Tukey’s HSD, p > .05). For the tobacco flavored ECIG, ratings were 
significantly increased pre- to post- bout 1 (Tukey’s HSD, p < .05), but significantly decreased 
pre-to post-bout 2 (Tukey’s HSD, p < .05). Further, ratings of “pleasant” were significantly 
higher for White participants post-bouts 1 and 2 with the fruit flavored ECIG, and post-bout 2 
with the tobacco flavored ECIG, compared to non-White participants (Tukey’s HSD, all p’s < 
.05). Finally, pre-bout 2 with the tobacco flavored ECIG, non-White participants had 
significantly higher ratings of “pleasant” than White participants (Tukey’s HSD, p < .05) .  
For the effects of session order (see Table 4), there was a significant main effect of order 
for “reduced hunger,” F (1, 29) = 5.40, p = 0.027, partial η2 = 0.16, such that hunger reduction 
was rated higher at the first session (M = 20.17, SE = 3.59) than at the second session (M = 
14.53, SE = 3.58; p < 0.05). There was also significant main effect of bout for “concentrate,” F 
(1, 29) = 9.38, p = 0.01, partial η2 = 0.24, such that values were significantly higher at bout 2 (M 
= 13.4, SE = 3.4) than at bout 1 (M = 5.5, SE = 1.3). There was also a main effect of time for 
“concentrate”, F (1, 29) = 15.32, p = 0.001, partial η2 = 0.35, where “concentrate” was rated 
higher post-bout (M = 13.8, SE = 3.1) than at pre-bout (M = 5.2, SE = 1.6). An order x time 
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interaction was present for both ratings of “calm” and “sick,” F’s > 7.41, p’s < .05, partial η2 > 
0.20. For “calm”, mean ratings were 10.4 (SE = 2.3) and 29.2 (SE = 4.8) pre- and post- bouts for 
session 1, respectively, and 7.9 (SE = 2.1) and 19.6 (SE = 4.1) pre- and post- bouts for session 2, 
respectively. Post-bout ratings were significantly higher than pre-bout ratings for both sessions, 
and post-bout ratings for session 1 were significantly higher than those for session 2 (Tukey’s 
HSD, p < .05). The same pattern emerged for ratings of “sick”, for which mean ratings were 6.3 
(SE = 2.1) and 22.1 (SE = 4.9) pre- and post- bouts for session 1, and 5.6 (SE = 1.9) and 13.7 (SE 
= 3.8; Tukey’s HSD, p < .05). Finally, significant bout x time interaction effects were present for 
all DEPS ratings other than “concentrate” (F’s > 8.56, p’s < 0.05, partial η2 > 0.23) such that 
scores increased significantly from pre- to post-bout 1 but not bout 2 (Tukey’s HSD, p < .05). 
For “taste good,” the measure with the largest F value for this interaction (F(1, 29) = 23.96, p  = 
.000, partial η2 = 0.45) means were 0.12 (SE = 0.06) and 33.5 (SE = 4.6) pre- and post- bout 1, 
respectively, and 23.3 (SE = 4.7) and 32.97 (SE = 4.97), respectively.  
Progressive Ratio Task. Table 5 displays mixed repeated-measures ANOVA results for 
PRT analyses with race included as a between-subjects factor. No significant difference was 
revealed between flavor conditions on any PRT outcomes, including when considered as a 
function of race (i.e., rewards earned, breakpoint, total responses, responses per minute, and 
latency to puff; Fs < 3.84, p’s > 0.05, partial η2 < 0.12). Descriptive statistics for all PRT 
outcomes for the main effect of flavor condition are displayed in Table 6. 
Probability Based Purchase Task. Table 5 also depicts mixed repeated-measures 
ANOVA results for all PBPT outcomes (i.e., breakpoint, demand intensity, demand elasticity, 
and AUC). Descriptive statistics for all PBPT outcomes are displayed in Table 6. No significant 
differences were found between flavor conditions for any outcome measure, or between flavor 
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condition x race (Fs < 0.27, p’s > 0.05, partial η2 < 0.01). Graphs of participant demand curves 
for fruit and tobacco flavored ECIGs are included in Figures 4 and 5, respectively.  
Secondary Outcome Measures 
Direct Effects of Nicotine Scale. Table 2 displays ANCOVA results for all DENS items. 
No significant main effects of flavor, bout, or time were revealed (F’s < 2.42, p’s > 0.05, partial 
η2 < 0.09). A significant flavor x time interaction effect was revealed for “dizzy,” F(1, 25) = 
4.85, p = 0.037, partial η2 = 0.16. Post-hoc comparisons (Tukey’s HSD, p < .05) revealed that 
ratings of dizziness were significantly higher post-bout compared to pre-bout for both fruit (Mpre-
bout = 3.97, SE = 1.3; Mpost-bout = 18.9, SE = 4.1) and tobacco flavors (Mpre-bout = 4.98, SE = 1.8; 
Mpost-bout = 17.2, SE = 4.1). No differences were revealed between flavor conditions (Tukey’s 
HSD, p’s > .05). Finally, there was a significant interaction effect of flavor x bout x time for 
“confused,” F(1, 25) = 4.75, p = 0.039, partial η2 = 0.16, as well as for the interaction between 
these factors and the risk covariate F(1, 25) = 9.56, p = .005, partial η2 = 0.28 (see Figure 6). 
Ratings of confused significantly increased from pre- to post-bout 1 within each flavor condition 
(Tukey’s HSD, p < .05); however, these increases were more pronounced for the first bout 
compared to the second bout. For bout 2, Tukey’s post-hoc tested revealed significant 
differences for pre-post bout  for tobacco flavor (Tukey’s HSD, p < 0.05), but no other 
meaningful differences.  
When examining race as a between-subjects factor (Table 3), there was a significant 
interaction effect of flavor x race for “sweaty,” F(1, 28) = 6.68, p = .015, partial η2 = 0.19. Non-
White individuals provided significantly lower ratings of sweatiness when using the tobacco (M 
= 8.3, SE = 5.9) compared to the fruit flavored ECIG (M = 18.0, SE = 7.6; Tukey’s HSD, p < 
.05), while White individuals reported comparable ratings between flavors (M = 5.5, SE = 3.4 
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and M = 5.5, SE = 2.6, respectively; Tukey’s HSD, p > .05). Non-White participants also had 
significantly higher ratings of “sweaty” than White participants when using the fruit flavored 
ECIG (Tukey’s HSD, p < .05). For “dizzy,” there was a significant time x race interaction, F(1, 
28) = 6.25, p = .019, partial η2 = 0.18, where there were significantly higher post-bout ratings of 
dizziness (M = 36.3 , SE = 8.6) compared to pre-bout (M = 7.1 SE= 2.99) for non-White 
individuals (Tukey’s HSD, p < .05), but not for White individuals (M = 14.4, SE = 3.8 and M = 
3.96, SE = 1.3, respectively; Tukey’s HSD, p > .05).  Post-bout, non-White participants had 
significantly higher ratings of “dizzy” than White participants (Tukey’s HSD, p < .05). A 
significant flavor x bout x race interaction was present for “nauseous,” F(1, 28) = 5.67, p = .024, 
partial η2= 0.17 (see Figure 7). For non-White individuals, mean ratings increased significantly 
from bout 1 to bout 2 for the tobacco-flavored ECIG only (Tukey’s HSD, p < .05). Further, bout 
2 ratings with the tobacco flavored ECIG were significantly higher for non-White participants 
than White participants (Tukey’s HSD, p < .05). For “lightheaded,” there was a significant effect 
of flavor x time x race, F(1, 28) = 5.25, p = .03, partial η2= 0.16, where ratings of 
lightheadedness significantly increased from pre- to post- bouts for all participants across races 
and flavors (see Figure 8; Tukey’s HSD, p  < .05). Post-bout with the fruit flavored ECIG, non-
White participants had significantly higher ratings of lightheadedness compared to White 
participants (Tukey’s HSD, p < .05). Finally, there was a significant bout x time x race 
interaction for “headache,” F(1, 28) = 4.92, p =.035, partial η2= 0.15 (see Figure 9).  For White 
individuals, there were no significant differences in means pre- to post-bout 1 or bout 2 (Tukey’s 
HSD, p > .05). However, for non-White individuals, there were significant increases in means 
pre- to post-bout 1 and bout 2 (Tukey’s HSD, p < .05). Post-bout means were significantly 
higher for non-White participants than for White participants (Tukey’s HSD, p < .05). 
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Significant main effects of order (i.e., collapsed across bout and time factors) were 
present for ratings of “dizzy,” “lightheaded,” “nauseous,” and “weak” (F’s > 4.70, p’s < 0.05, 
partial η2 > 0.14 ) (see Table 4). For all four DENS items, ratings were significantly higher at 
session 1 than at session 2. For “lightheaded,” the item with the largest F value for the main 
effect of order (F(1, 29) = 12.44, p = .001, partial η2 = .30), mean scores at session 1 were 19.0 
(SE = 2.8) compared to 11.3 (SE = 2.1) at session 2. Significant main effects of bout were 
present for ratings of “lightheaded,” “nervous,” and “heart pounding” (F’s > 4.35, p’s < 0.05, 
partial η2 > 0.13). Participants reported significantly higher levels of “lightheadedness” at bout 2 
(M = 17.2, SE = 2.6) compared to bout 1 (M = 13.1, SE = 2.2). The opposite trend was revealed 
for “nervous” and “heart pounding” where ratings at bout 1 (M = 9.3, SE = 2.7 and M = 8.9, SE = 
2.4, respectively) were higher than at bout 2 (M = 6.6, SE = 2.2 and M = 6.9, SE = 1.8, 
respectively). Main effects of time were also present for “dizzy,” “lightheaded,” “nauseous,” and 
“weak” (F’s > 4.51, p’s < 0.05, partial η2 > 0.14). For all four outcomes, scores were higher 
post- bout compared to pre- bout. For “lightheaded,” the item with the largest F value for the 
main effect of time (F(1, 29) = 33.09, p = .00, partial η2 = .53), mean pre- bout scores were 5.8 
(SE = 1.2) compared to 24.5 (SE = 3.7) post-bout. Finally, there was a bout x time interaction for 
“sweaty”(F (1, 29) = 5.92, p = 0.02, partial η2 = 0.17), though post-hoc tests did not reveal 
significant differences between time points at either bout (Tukey’s HSD p > .05). For bout 1, 
mean pre- to post-bout sweaty ratings were 7.8 (SE = 3.2) and 6.98 (SE = 2.7), respectively. For 
bout 2, these values were 5.0 (SE = 2.7) and 7.3 (SE = 2.7), respectively. 
Puff Duration. No significant main or interaction effects were revealed for puff duration 
(F’s < 0.85, p’s > 0.05, partial η2 < 0.03; Table 2). Collapsed across time, mean puff duration 
was 2.4 seconds (SE = 0.2) for fruit flavor and 2.5 seconds (SE = 0.2) for tobacco flavor. No 
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significant effects were revealed when including race as a between-subjects factor (F’s < 0.84, 
p’s > 0.05, partial η2 < 0.03; Table 3). 
For the effects of session order (see Table 4), there was a significant main effect of bout 
[F (1, 29) = 11.27, p = 0.002, partial η2 = 0.28], such that participants took longer puffs at bout 2 
(M = 2.5 seconds, SE = 0.2) than at bout 1 (M = 2.3, SE = 0.2).  
Physiological Measures. A significant main effect of flavor (collapsed across bout and 
time factors) was revealed for systolic blood pressure (F (1, 26) = 5.34, p = 0.029, partial η2 = 
0.17; Table 2), where systolic pressure was higher for the tobacco condition (M = 120.4 mmHg, 
SE = 2.2) than for the fruit condition (M = 116.8 mmHg, SE = 2.6). Systolic blood pressure also 
revealed a significant bout x time interaction (F(1, 26) = 6.46, p = 0.017, partial η2  = 0.20) 
including when accounting for the covariate of lifetime ECIG use, F(1, 26) = 12.64, p = 0.002, 
partial η2  = 0.32. However, post-hoc tests did not reveal any significant differences in means 
across time points or bouts (Tukey’s HSD, p > .05). Mean systolic blood pressure was 116.1 
mmHg (SE = 2.8) pre-bout 1 compared to 120.2 mmHg (SE = 2.4) post-bout 1, and 116.98 
mmHg (SE = 2.6) pre-bout 2 compared to 120.5 mmHg (SE = 2.1) post-bout 2.  There was a 
significant main effect of time for heart rate, F(1, 25) = 7.44, p = 0.011, partial η2  = 0.22, where 
heart rate was significantly higher post-bout (M = 85.5 bpm, SE = 1.8) compared to pre-bout (M 
= 82.3 bpm, SE = 1.5). 
When examining race as a between-subjects factor (see Table 3), a significant interaction 
effect of flavor x bout x race was revealed for diastolic blood pressure, F(1, 26) = 5.68, p = .025, 
partial η2 = .18 (see Figure 10). For differences between conditions and bouts, bout 2 was 
significantly higher than bout 1 for non-White participants using the fruit flavored ECIG only 
(Tukey’s HSD, p < .05). Non-White participants had significantly higher diastolic pressure than 
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White participants at bout 2 using the fruit flavored ECIG and at bout 1 using the tobacco 
flavored ECIG (Tukey’s HSD, p < .05). An interaction effect of bout x time x race was revealed 
for heart rate, F(1, 26) = 11.05, p = .003, partial η2 = .30 (see Figure 11). Across racial groups, 
there was a significant heart rate increase pre- to post- bout 1 (Tukey’s HSD, p < .05) but not 
bout 2 (Tukey’s HSD, p > .05). Additionally, pre-bout 1 White participants had significantly 
higher heart rates than non-White participants (Tukey’s HSD, p < .05). Further, interaction 
effects of flavor x bout x time x race were revealed for all three physiological outcome measures 
(Fs > 4.65, ps < .05, partial η2 > 0.15). For heart rate, pre-post bout values increased 
significantly for all but non-White individuals at bout 2 using the tobacco flavored ECIG (see 
Figure 12; Tukey’s HSD, p <.05).  For systolic blood pressure, only differences in pre-post bout 
1 values for non-White individuals using the tobacco flavored ECIG were significant (see Figure 
13; Tukey’s HSD, p < .05). Further, non-White individuals had significantly higher systolic 
blood pressure readings for the majority of time points measured (i.e. for fruit: pre-bout 1, pre-
bout 2, post-bout 2, and for tobacco: post-bout 1, pre-bout 2; Tukey’s HSD, p < .05).  Finally, for 
diastolic blood pressure, non-White participants had significantly higher diastolic blood pressure 
readings than White participants post-bout using the fruit flavored ECIG, as well as post-bout 1 
and pre-bout 2 with the tobacco flavored ECIG (See Figure 14; Tukey’s HSD, p < .05).  
When analyzing order effects (see Table 4), no significant main effects of order were 
detected for any physiological outcome measure (Fs < 1.84, p’s > 0.05, partial η2 < 0.06). 
Significant main effects of time were present for both systolic and diastolic blood pressure (F’s > 
6.41, p’s < 0.05, partial η2 > 0.19), such that values were significantly higher post-bout (M = 
120.4 mmHg, SE = 2.1 and M = 71.2 mmHg, SE = 1.3, respectively) compared to pre-bout (M = 
116.5 mmHg, SE = 2.5 and M = 68.9 mmHg, SE = 1.3, respectively). An interaction effect of 
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order x bout x time was detected for heart rate, F (1, 27) = 12.61, p = .001, partial η2 = 0.32 (see 
Figure 15). Generally, heart rate increased from pre- to post-bouts 1 and 2 within each session. 
Heart rate was significantly higher post-bout than pre-bout across sessions and bouts (Tukey’s 
HSD, p < 0.05), with the exclusion of post-bout 2 in session 1 (Tukey’s HSD, p > 0.05). 
Additionally, heart rate post-bout 2 at the first study session was significantly lower than heart 
rate post-bout for all other puffing bouts across sessions (Tukey’s HSD, p < 0.05).  
Generalized Labeled Magnitude Scale. Table 2 shows no significant main or 
interaction effects were revealed for any gLMS item (F’s < 4.09, p’s > 0.05, partial η2 < 0.26). 
Collapsed across time, the mean rating of flavor sensation was 30.3 (SE = 4.5) for fruit flavor 
and 26.7 (SE = 5.1) for tobacco flavor. For harshness, mean ratings were 42.7 (SE = 5.8) for fruit 
and 34.7 (SE = 5.2) for tobacco, and mean ratings of throat hit were 43.5 (SE =5.96) for fruit and 
38.1 (SE = 6.0) for tobacco. A significant bout x race interaction (Table 3) was detected when 
examining race as a between-subjects factor for sensation, F(1, 15) = 4.73, p < .05, partial η2 = 
0.24. For White participants, ratings were 28.8 (SE = 4.7) and 32.8 (SE = 4.7) for bouts 1 and 2, 
respectively, and 20.0 (SE = 10.1) and 15.0 (SE = 10.2) for non-White participants, respectively. 
For both bouts, White participants had significantly higher ratings of sensation than non-White 
participants (Tukey’s HSD, p < 0.05; Table 3). There were no significant effects for the gLMS 
measure involving the session order factor (F’s < 0.07, p’s > 0.05, partial η2 < 0.01; see Table 
4).  
ECIG Risk Perception. The mean perceived risk score for participants was 5.3 (SD = 
1.4), on a scale that ranged from 0 to 9. Average scores were relatively low for two of the three 
items, reflecting agreement with statements suggesting that ECIGs can be used as a smoking 
cessation tool (M = 1.6, SD = 0.8) and as a harm reduction product (M = 1.2, SD = 0.8). 
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However,  participants generally did not agree with the statement that ECIGs are less addictive 
than cigarettes (M = 2.5, SD = 0.7) 
ECIG Outcome Expectancies. Overall, participants reported higher negative ECIG 
outcome expectancies (M = 21.7, SD = 4.4) than positive (M = 11.8, SD = 7.0). Means and 
standard deviations for ECIG outcome expectancies, including individual items, are depicted in 
Table 9. 
Flavor Discrimination. The majority of participants (82.35%; n = 14 of 17) who were 
asked to identify the order of ECIG flavors used by visit responded correctly.  
Exit Interview. Table 8 displays flavor preferences and frequencies for all participants. 
Overall, participants described liking flavors that were sweet/fruity and did not burn. The top 
preferred flavors included mint/menthol (n = 10), mango (n = 7), and berry/berry medley (n = 5). 
Some participants also reported favoring flavors modeled after sugary drinks (i.e., pink 
lemonade, grape soda; n = 2) and cereals (i.e., fruit loops and fruity pebbles; n = 2). Six 
participants reported a dislike of all flavors that they have tried (i.e., prefer no flavors). Among 
the flavors most disliked by participants were mint/menthol (n = 9) and tobacco (n = 8), though 
the majority stated that they do not dislike any flavors (n=10).  
Participant responses to the exit interview, which are categorized according to themes, 
are presented in Table 9. Responses from the participants who provided a reason for liking or 
disliking flavors, as described above, are summarized. All 30 participants reported that their 
ECIG use occurred primarily or exclusively in social settings. The most common reasons for 
using an ECIG included were curiosity (n = 17), social pressure (n = 16), and flavor (n = 11). 
Note that some participants listed more than one reason for use. Interestingly, only 4 participants 
described using an ECIG because they enjoyed the experience (e.g. sensory or physiological).  
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Participants also responded to several questions regarding their study experience. Overall, 
the majority of participants (n = 22) reported that the amount of product used in the study session 
was more than they would normally consume in their natural environment. Self-reported reasons 
for participating in the study included compensation (n = 19) and a desire to contribute to 
research (n = 9). Some participants (n = 6) noted that they felt that it was important to further 
research on electronic cigarettes, in particular. Aspects of the study that participants most 
frequently reported disliking included the long wait in between tasks (n = 5), having to use the 
ECIG (n = 3), and the length of study sessions (n = 2). Participants reported that the study room 
was comfortable (n = 6). Some participants noted that they enjoyed having time to rest in 
between sessions (n = 2) and using the ECIG as part of the study (n = 2). Note that 43% and 57% 
of participants did not report any aspects of the study which they disliked or liked, respectively.  
Discussion 
The risk of ECIG product initiation by tobacco-naïve youth and young adults remains a 
pressing public health concern in the United States. In light of the recent documented increase in 
ECIG use among youth and young adults (Gentzke et al., 2019; Dai & Leventhal, 2019), the 
FDA has identified the use of non-tobacco flavors that are appealing to youth as a target for 
potential product regulation (FDA Regulation of Electronic Nicotine Delivery Systems and 
Investigation of Vaping Illnesses, 2019). Cross-sectional research largely supports the theory that 
flavored ECIG products are particularly appealing to this population, as the majority of them 
report initiating ECIG use with a sweet flavored product (McKelvey, Biaocchi & Halpern-
Felsher, 2018). The use of a sweet (vs tobacco) flavored ECIG, particularly during the period of 
initial use, may increase later tobacco use due to a) reduction of the initial aversive effects of 
nicotine, b) learned association between reinforcing a olfactory cue and nicotine delivery , and c) 
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metabolic properties of certain flavors that may increase the bioavailability of nicotine 
(Wickham, 2015). These findings have been capitalized on by the tobacco industry in the past to 
recruit new generations of users of other tobacco products (e.g., smokeless, cigars) (David Weiss 
Associates, 1987; Kostygina & Ling, 2016). Despite this, limited experimental work exists on 
the role of flavoring in ECIG abuse liability among tobacco-naïve young adults. As such, the 
findings of the current study can help to complement existing research in order to inform future 
regulatory decisions. 
Nicotine Delivery 
A key factor in the conceptualization of flavor as a driver of abuse liability of tobacco-
products lies in its ability to mask the harsh sensory experience (e.g., throat burning, taste) 
associated with tobacco/nicotine effects (Carpenter et al., 2005; Cummings et al., 2002). Thus, 
examining the abuse liability of flavored ECIGs requires the use of a device capable of nicotine 
delivery. In the current study, measures of heart rate, which are commonly used markers of 
nicotine delivery (Jolma et al., 2002; Omvik, 1996), were increased significantly from pre- to 
post-ECIG bouts within each flavor condition. Increases in heart rate in response to a 
standardized 10-puff ECIG bout have been reported in previous work using JUUL with ECIG-
naïve cigarette smokers, where heart rate increased from 63.7 bpm (SE = 2.7) to 73.9 bmp (SE = 
2.4) from pre- to post-bout respectively (Maloney et al., 2019b). This effect is also seen for 
ECIG experienced users following a standardized 10-puff bout with an older generation of ECIG 
(Spindle et al., 2018). Differences in heart rate were less pronounced in the current study 
(differences of about 3 bpm) compared to differences found in prior work (7 – 13 bpm; Maloney 
et al., 2019a; Maloney et al., 2019b; Spindle et al., 2018). Taken together, these data suggest that 
the JUUL device is capable of delivering physiologically active doses of nicotine to tobacco-
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naïve individuals, albeit at lower levels compared to those demonstrated in this previous work 
with ECIG experienced users and ECIG-naïve cigarette smokers. Differences across studies may 
be due to differences in the device characteristics that were used (e.g., liquid nicotine 
concentration; battery power) and/or the puff topography patterns observed (e.g., size and/or 
volume of puffs).  
Subjective Ratings of ECIGS 
Overall, few significant effects emerged for subjective ratings as a function of ECIG 
flavor. One possible reason for this pattern is a floor effect, as ratings across subjective measures 
were notably low for both flavors. For example, mean ratings for 100-point VAS subjective 
items (e.g. lightheaded, nauseous, taste good, pleasant) ranged from 3.1 to 22.5 (SD’s 9.1 to 
27.9). These findings contribute to the currently mixed literature, which is largely based on adult 
populations with varied ECIG and cigarette use histories. For instance, no differences were 
found in subjective ratings of enjoyment between strawberry and tobacco ECIG flavors in adult 
ECIG-experienced users with minimal cigarette smoking history (St. Helen et al., 2017). In 
contrast, another study found that hedonic ratings of sweet ECIG flavors (e.g., piña colada, peach 
schnapps) were higher than for non-sweet flavors (e.g., classic tobacco) in adult experienced 
ECIG users or dual users of both ECIGs and cigarettes (Kim et al., 2016).  Further, a study 
assessing subjective appeal among young adult JUUL users (18 – 25 years) found that young 
adults rated their “preferred” flavored ECIGs (71.4% mint, 14.3% menthol, 14.3% mango) as 
significantly more favorable (e.g., “wanting more”) than tobacco flavored ECIGs (Pacek, 
Kozink, Wimbish & McClernon, 2019). Notably, no experimental work has been completed 
within tobacco-naïve users in this age group. As such, some of these differences in findings may 
be attributed to differences in the study sample, given that tobacco-naïve young adults 
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demonstrate low subjective ratings of ECIG products, overall.  Additionally, differences between 
study results may be related to differences in ECIG model, flavors, nicotine concentration, and 
PG/VG ratios used.  
Behavioral Economic Outcomes 
 Outcomes for tasks measuring willingness to pay and work for the ECIG (e.g. PBPT, 
PRT) also did not reveal significant differences between flavors. These findings differ from prior 
work in young adult JUUL users (18 – 25 years), in which participants completed a concurrent 
choice task in which they could expend effort for fixed doses of JUUL vapor in either a 
“preferred” flavor (e.g., mint, menthol, or mango) or tobacco flavor. Effort required to earn a 
dose from the preferred flavored pod was on an escalating schedule while effort required for the 
tobacco flavored pod was on a fixed schedule. Participants made greater choices (i.e., expended 
greater effort by responding more) for preferred compared to tobacco flavored pods (7.9 vs. 3.6; 
Pacek, Kozink, Wimbish & McClernon, 2019). Findings from the present study also differ from 
previous work in adult experienced ECIG users who report using < 15 tobacco cigarettes per day, 
which found that participants were willing to pay more for sweet compared to non-sweet flavors 
(Goldenson et al., 2016). Other studies have found differences in purchase task and PRT 
outcomes for flavored compared to non-flavored ECIGs among cigarette smokers (Audrain-
McGovern, Strasser & Wileyto, 2016; Barnes et al, 2017). Barnes et al. (2017), for example, 
used a cigarette purchase task in a sample of smokers with no history of regular ECIG use (never 
used weekly for > 1 month). Participants were asked to provide the number of times that they 
would be willing to take 10-puffs from a tank-style (second generation) ECIG at a range of 
prices (per $10 puffs) from $0 to $10.24. Mean demand intensity for participants was 0.04 for 
the cherry flavored ECIG and 0.11 for the unflavored ECIG. These patterns are similar to data 
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from the current study where mean demand elasticity was 0.0004 (SD = .002) for the fruit 
flavored ECIG and 0.001 (0.007) for the tobacco flavored ECIG. However, the latter elasticity 
values are considerably lower. While this suggests inelasticity of demand, which is usually 
considered a marker of abuse liability, these values are a function of low probability of purchase 
across prices rather than high probability. This is demonstrated in the present study by AUC 
values of 0.06 (0.08) for both flavors, indicating that probability of consumption across 
participants and flavors was only 6% of total possible consumption. In contrast to the present 
PBPT findings, though, Barnes et al. (2017) did reveal significant differences in demand 
intensity, where participants were reported willingness to take 10.25 10-puff bouts of cherry 
flavored and 8.44 10-puff bouts of the unflavored ECIG when the price was $0. Though 
assessing two flavored ECIGS, participants from the present study did not differ on probability 
of purchase at $0 between fruit and tobacco flavored products (M = 68.9, SD = 77.97 and M = 
75.1, SD = 83.98, respectively). PRT data in the current study also differs from prior work by 
Audrain-McGovern et al. (2016) in which smokers (with at least one reported ECIG use) worked 
harder for flavored compared to unflavored ECIG puffs, during a 10-trial task in which they 
could respond on a fixed-ratio (FR) 25 schedule of responding (via mouse clicks) for a puff from 
an unflavored ECIG or on a progressive-ratio (PR) schedule of 25x for a puff from a flavored 
ECIG. Breakpoint for flavored puffs was 597 responses compared to 127 responses for 
unflavored, and participants took twice as many puffs from the flavored, compared to the 
unflavored ECIG (40 vs 23 puffs). In comparison, participants from the present study took an 
average of 3.5 (5.7) puffs from the fruit flavored ECIG and 3.5 (6.1) from the tobacco flavored 
ECIG and had breakpoints of 112.8 (243.2) and 136.2 (298.4), respectively. 
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   The discrepancy in findings between the present study and prior work may be the result 
of an important difference between samples of regular ECIG or cigarette users and one that is 
tobacco-naïve – the motivating presence of nicotine withdrawal. Indeed, for two of the three 
aforementioned studies, participants were required to abstain from product use overnight in order 
to induce nicotine withdrawal. In the present study, only 13 participants made enough responses 
to earn at least one reward (one puff from the ECIG) at both sessions. Further, low overall 
subjective ratings for product liking suggest a potential floor effect in which participants’ 
willingness to work for either product is too low to distinguish meaningful differences between 
the two. Given this, and the lack of nicotine withdrawal, it stands to reason that many 
participants were not motivated to pay or work for either ECIG flavor. 
Race Effects 
 For physiological measures and subjective effects, some significant race effects were 
found such that measures associated with nicotine exposure (e.g. heart rate, dizzy, nauseous, 
headache, sick) increased significantly between bouts or time points for non-white but not white 
participants. Importantly, significant differences were also consistently observed between race 
groups. For example, reported ratings of “sick,” “dizzy,” and “lightheaded” were significantly 
higher for non-White participants than for White participants at various time-points. These 
findings suggest that non-White participants may be more sensitive to some of the aversive 
effects of nicotine commonly perceived by tobacco-naïve individuals.  
This finding might be explained by work demonstrating race differences in smoking 
patterns and nicotine metabolism (St. Helen, Dempsey, Wilson, Jacob & Benowitz, 2013). Racial 
differences in nicotine metabolism, in particular, have been attributed to the activity of the liver 
enzyme CYP2A6, which is responsible for conversion of nicotine into its metabolite, cotinine 
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(National Center for Biotechnology Information, 2019). Specifically, gene variants (a.k.a. 
polymorphisms of the gene by the same name, CYP2A6) on chromosome 19 that code for the 
function of this enzyme have been shown to result in differences in nicotine metabolism 
(Oscarson et al., 1999; Nunoya et al., 1999; Yoshida et al., 2003) with varying prevalence rates 
between racial and ethnic groups (Nakajima et al., 2006; Schoedel, Hoffman, Rao, Sellers & 
Tyndale, 2004). Specifically, Black/African American and Asian individuals have each been 
found to have a higher proportion of genetic polymorphisms associated with decreased nicotine 
metabolism (Nakajima et al., 2006; Schoedel, Hoffman, Rao, Sellers & Tyndale, 2004; Tanner & 
Tyndale, 2017), and to demonstrate a slower elimination rate than White individuals when they 
consume nicotine (Benowitz, Perez-Sable, Herrera & Jacob, 2002; Ross et al., 2016). In cigarette 
smokers, the rate of nicotine metabolism is associated positively with the rewarding effects of 
nicotine. For example, fast nicotine metabolizers self-report more positive nicotine effects (i.e., 
“good effects,” “like the drug effects,” “want more drug”) than slower metabolizers following a 
period of overnight tobacco abstinence (Sofuoglu, Herman, Nadim & Jatlow, 2012). On the other 
hand, some studies suggest that relatively slow nicotine metabolism is associated with greater 
sensitivity to the rewarding nicotine effects (i.e., more time spent in a nicotine-associated 
compartment in a conditioned place preference test in mice; Li et al., 2013; also see Karp, 
O’Loughlin, Hanley, Tyndale & Paradis, 2006 and O’Loughlin et al., 2004).  
Though the pattern of findings from the present study seem to support the idea that racial 
minorities may experience significantly stronger aversive nicotine effects, only 9% of all 
possible race effects were significant. Importantly, some of these findings may alternatively be 
explained by differences in flavor-order; as 4 of the 5 non-White participants received the 
tobacco flavored ECIG during the first study session. Indeed, for all participants, ratings of 
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nicotine effects (e.g., dizzy, lightheaded, nauseous) were significantly during the first compared 
to the second study session. Thus, differences in flavor ratings across race groups may be an 
artifact of the flavor received at session 1 rather than differences in metabolism.  Additionally, 
while not statistically significant, mean lifetime ECIG use was lower for non-White participants 
(M = 10.5, SD = 5.8) compared to White participants (M = 12.8, SD = 10.8). Given the very 
small number of non-white individuals in the present sample (n = 5), analyses may not have been 
adequately powered to detect significant differences in lifetime use between groups; however, in 
a more diverse sample this pattern may better explain the observed differences in outcomes 
between race groups. As such, exploration of this pattern in a large-scale study is critical in order 
to fully understand these findings.  
Strengths 
There are several components of the present study which underlie its contribution to the 
existing literature on the abuse liability of flavoring in tobacco naïve young adults. Firstly, no 
other work has experimentally examined flavor preference in this population. In addition, the use 
of a within-subjects design increases confidence that findings are due to condition differences 
rather than due to between group variability. The combination of both subjective and behavioral 
outcomes also allowed the researchers to assess both perceptions of ECIG flavors, as well as 
their effects on behavior. Finally, given its current popularity both across ECIG users and among 
young adults, use of the JUUL device makes the results of this study particularly relevant to the 
national discussion regarding the regulation of ECIG products and strategies for preventing 
initiation by tobacco-naïve youth and young adults.  
Limitations 
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Despite these study strengths, there are a variety of factors which may explain the overall 
paucity of significant results and limit the generalizability of these. The first limitation is that the 
majority of participants had very low levels of lifetime ECIG use (< 10). These individuals may 
be representative of a certain sub-category of naïve users who are willing to sample the product 
but who do not intend to initiate regular product use. However, it is possible that non-users with 
higher lifetime use (< 100 but > 50) may exhibit different patterns across outcomes. Naïve users 
with low levels of lifetime use appear to dislike using the electronic cigarette, as evidenced by 
overall low subjective ratings of product liking, lack of responding during the purchase task, and 
self-reports during the exit interview. For example, when comparing the five participants with 
the highest lifetime use (20 – 50 lifetime uses), reported mean scores ranging for ratings of 
product enjoyment (i.e., satisfying, pleasant, taste good) ranged from 26.8 to 31.4 (SD  = 26.8 – 
27.6).  Comparatively, ratings for the five participants with the lowest lifetime use (3 to 4 
lifetime uses) ranged from 22.3 to 25.4 (SD = 24.3 – 26.5).   While these differences are 
relatively small, the effect might be magnified in a larger sample including more experience 
ECIG users.  Future research should include non-users with a wider range of lifetime use in order 
to assess for differences in flavor preference and corresponding behavior based on ECIG 
experience. 
The exit interview revealed that, while all of the participants had used an ECIG on more than 
one occasion, only six of the 30 participants reported product enjoyment as a reason for use. 
Moreover, these six individuals had varied number of lifetime ECIG uses: 3 lifetime uses (n = 1), 
10 lifetime uses (n = 2), 15 lifetime uses (n = 1), and 20 lifetime uses (n = 1). This may be 
suggestive in differing motivations for use among ECIG naïve users with low lifetime use. 
Indeed, throughout exit interviews, all participants described using the product in social settings. 
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Notably, none of the participants used ECIGs without a peer present. Further, reasons such as “to 
fit in” and “peer pressure,” were given for product initiation and continued experimentation 
despite 20% of participants reporting not liking the flavor of any ECIG that they had tried.  Many 
participants also reported using the ECIG concurrently with alcohol, in settings such as parties, 
bars, the lake, or friends’ houses. This is consistent with prior work regarding self-reported 
reasons for ECIG experimentation among young adults, which found that peer influence was one 
of the top three reasons for experimentation (Kong, Morean, Cavallo, Camenga, & Krishnan-
Sarin, 2015). In particular, young adults in the Kong et al. (2015) study reported being offered an 
ECIG by a friend or family member as a common reason for experimentation. Given the social 
nature of ECIG use among this sample, it is likely that the laboratory environment was not 
conducive to the enjoyment of the product.  
Further, puffing behavior during directed bouts may have been influenced by the researcher’s 
presence and effects of social desirability. While the majority of participants reported low ratings 
of product enjoyment (e.g., mean ratings of “pleasant,” “satisfying,” “taste good” = 18.9 – 22.5, 
SE = 2.3 – 3.4), average puff duration (M =  2.4 seconds, SE = 0.14) was consistent with that 
recorded in prior work with ECIG-naïve adult cigarette smokers (M = 2.3 seconds, SD = 0.2 
seconds;  Farsalinos et al., 2014), though lower than that recorded in work with adult 
experienced ECIG users (M = 3.5 seconds, SD = 0.2 - 1.4 seconds; Farsalinos et al., 2015; St. 
Helen et al., 2017). Thus, despite self-reported dislike of the product, participants may have 
taken longer puffs than usual based on these demand characteristics. 
In addition to challenges which may have been posed by a laboratory setting, aspects of the 
study design may also have affected participant behavior. The current study used a standard 10-
puff directed bout in which participants were instructed to puff from the ECIG every 30-seconds, 
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for 5-minutes. This bout structure has commonly been used in research using combustible 
cigarettes and older ECIG models (Spindle et al., 2015a; Vansickel et al., 2010; Vansickel & 
Eissenberg, 2013). However, recent work suggests that, when allowed to smoke ad libitum, even 
experienced ECIG users do not puff in this pattern (Felicione, 2019; St. Helen et al., 2016). In 
one study, ECIG puffs were clustered into those considered “small” (2 – 5 puffs), “medium” (6 – 
10 puffs), or “large” (>10 puffs) assuming that the time in between those puffs was <60 seconds 
while single puffs were those with > 60 seconds separating them from puffs before and after (St. 
Helen et al., 2016). When experienced ECIG users puffed on their own device (cartridge-style, 
tank-style, or mod-style) ad libitum for 90 minutes, the majority were classified as “small” (43%) 
compared to “medium” (28%), “large” (17%), or single (12%) (St. Helen, et al., 2016). In work 
conducted in our laboratory (Felicione, 2019), ECIG-experienced users who puffed on their 
usual ECIG device (64% of which were JUUL) demonstrated 49.4% “small,” 7.8% “medium,” 
0.0% “large,” and 41.9% single puffs. These results are consistent with the abovementioned 
study (St. Helen et al 2016) in that the proportion of small clustered puffs was greater than 
medium and large clustered puffs. On the other hand, our study demonstrated a notably high 
proportion of single puffs, as well as fewer medium and large puffs. (Felicione, 2019). This 
preference for shorter puffing bouts may be due to the higher nicotine concentration found in 
liquid for pod-mod style ECIG devices, relative to older generations. For example, , JUUL liquid 
contains 59 mg/ml. In fact, when tested, some JUUL pods have been found to contain nicotine 
concentrations as high as 75 mg/ml (Eissenberg et. al, 2018; Talih et. al, 2019). However, a study 
comparing plasma nicotine concentration in adult smokers following directed 10-puff bouts with 
either JUUL or own-brand combustible cigarettes found that plasma levels were lower following 
JUUL use (7.1 ng/ml) than following cigarette use (22.5 ng/ml) (Maloney et al., 2019b).  In light 
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of these findings, it is likely that the standard 10-puff bout may be less appropriate for modeling 
naturalistic ECIG-use among pod-mod users, although this difference is not necessarily 
explained by differences in nicotine delivery. For tobacco naïve young adults, however, this 
amount does appear to exceed that which they would normally consume. This is reflected in exit 
interview reports, in which 73% of participants noted that the amount of ECIG liquid consumed 
in the session was more than what they would normally consume. Given these findings, 
development of a more appropriate standard puffing bout for newer generations of ECIGS may 
be necessary. 
The study design may have also been limited by the lack of variety of ECIG flavor options 
for participants. While at the time of study development, fruit flavors were particularly popular 
(Ford et al., 2016; Soneji, 2019; Wang et al., 2015), flavor preference among young adults may 
also include mint, dessert, beverage and candy flavors. However, the majority of study 
participants reported preferring mint/menthol flavor (n = 10). Of note, JUUL pulled flavors other 
than mint and tobacco from the market during the course of the present study, which may have 
influenced this shift in self-reported preference. Indeed, recently published data collected in 2018 
suggests that JUUL users were more likely to use the product with a mint/menthol flavor than 
users of other ECIG devices (Weaver et al., 2019). Given the shifting landscape of flavor 
regulations and trends, future work might include more flavor options in order to account for this 
and the heterogeneity of flavor preferences in this population. 
 Finally, due to the large number of analyses conducted (See Tables  2 – 5), the potential 
for experiment-wise Type I error rate for these results may be inflated. This number of analyses 
was utilized in order to fully investigate all potential effects in the present sample; however, 
results must be interpreted cautiously. Thus, significant effects should be interpreted with respect 
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to effect size, which is less sensitive to Type I error inflation (Ranganathan, Pramesh, & Buyse, 
2016; Sullivan & Feinn, 2012). In the present study, partial eta squared values were reported, 
which reflect the proportion of total variance in a particular outcome which is associated with the 
independent variable. Effect sizes for significant differences were small to medium (partial η2 = 
0.14 to 0.61), with larger effect sizes reflecting higher potential for reliability of an effect. Future 
work may consider recruiting a larger sample in order to increase study power or reducing the 
number of comparisons made to preserve the Type I error rate. Cautious interpretation of results 
and an emphasis on effect size will also aid in appropriate interpretation of results.  
Conclusions and Future Directions 
 Results from the current study suggest that tobacco-naïve young adults with low levels of 
lifetime ECIG use may not respond differently to tobacco and fruit JUUL flavors. However, 
participants reported finding the device significantly more pleasant after the second compared to 
the first puffing bout in each session and reported lower levels of nicotine-driven subjective 
effects at the second compared to the first study session, indicating potential habituation to 
nicotine effects in a relatively short period of time. Further, the population identified in the 
present sample may be unique in their willingness to use ECIG products in social settings but 
without a desire to work for or use the product outside of these settings. A potential protective 
factor among these individuals may be their reported higher negative outcome expectancies 
compared to positive outcomes expectancies related to ECIG use. Expectancy ratings were 
highest for negative ECIG outcomes such as “hurt lungs” (M = 6.97, SD = 2.1) and “become 
addicted” (M = 6.7, SD = 2.6), and lowest for outcomes such as “become more popular” (M = 
2.3, SD = 2.5) and “smell good” (M = 2.7, SD = 2.5). Regarding risk perception, the majority of 
participants (73.3%) reported agreeing with the statement “electronic cigarettes can help people 
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quit smoking” and 50% agreed with the statement “electronic cigarettes are less harmful than 
regular cigarettes”. However, only 13.3% of participants agreed with the statement “electronic 
cigarettes are less harmful than regular cigarettes.” Taken together, this suggests that despite 
reported social motivations for product use, this population of young adults perceives greater 
costs than benefit from ECIG use. While they believe that ECIGs may represent a helpful quit 
aid, the majority of participants did perceive risk of addiction associated with use.  These 
expectancies and beliefs may underlie reported disinterest within this sample in engaging in 
regular ECIG use, despite willingness to sample the product in a social context. Future work 
should assess these outcomes across a wider range of non-users in order to clarify whether these 
same patterns hold for non-users with higher levels of lifetime ECIG use. Further, given changes 
in device styles and flavor popularity changes to future study designs should include lower 
puffing requirements during directed bouts and choice of a wider range of product flavors.  This 
research is the first to experimental assess abuse liability of flavor among a sample of tobacco 
naïve young adults, and results suggest that among naïve users with low lifetime use there may 
be factors other than flavor which motivate product use and susceptibility. 
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Table 2 
Gender
     Male
     Female
Race 
     Caucasian
Black/ African 
American
Asian
>1 race
Ethnicity
Non-Hispanic/Latino
Age (Years)
     Student
     Full-time
     Part-time
     Unemployed
Expired Air CO (ppm)
     Mango
     Fruit Medley
19.43 (1.36)
83.30%
12.37 (10.12)
56.67%
43.33%
3.33%
2.13 (1.61)
3.30%
1.13 (0.35)
83.33%
6.67%
6.67%
Liquid Fruit Choice
# Lifetime ECIG Uses
Urinary Cotinine (ng/ml)
100%
Participant Baseline Characteristics
M (SD) or %
63.33%
36.67%
Employment
3.30%
10.00%
FLAVORS IN ECIG ABUSE LIABILITY IN NON-TOBACCO YOUTH 
 
 
72 
 
Repeated Measure ANCOVA Results by Flavor 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3 
Outcome Measure F p ηp
2
F p ηp
2
F p ηp
2
F p ηp
2
F p ηp
2
F p ηp
2
F p ηp
2
Physiological Measures
a
Heart Rate 0.47 0.500 0.02 2.69 0.113 0.09 7.44 0.011 0.22 0.64 0.430 0.02 0.67 0.419 0.03 1.03 0.320 0.04 0.43 0.516 0.02
Systolic 5.34 0.029 0.17 0.15 0.299 0.04 3.00 0.095 0.10 0.22 0.645 0.01 0.07 0.792 0.00 6.46 0.017 0.20 1.51 0.230 0.06
Diastolic 1.24 0.276 0.05 0.50 0.485 0.02 1.47 0.236 0.05 0.25 0.624 0.01 0.22 0.641 0.01 1.12 0.300 0.04 0.01 0.915 0.00
Direct Effects of Nicotine
b
Dizzy 0.48 0.494 0.02 0.42 0.524 0.02 0.13 0.724 0.01 1.32 0.261 0.05 4.85 0.037 0.16 0.14 0.715 0.01 0.03 0.860 0.00
Lightheaded 2.39 0.135 0.09 0.08 0.787 0.00 0.39 0.540 0.02 0.02 0.890 0.00 2.94 0.099 0.11 0.30 0.592 0.01 0.08 0.784 0.00
Nauseaus 0.69 0.415 0.03 0.30 0.590 0.01 0.10 0.754 0.00 2.72 0.112 0.10 0.26 0.616 0.01 2.51 0.126 0.09 0.02 0.878 0.00
Nervous 0.66 0.424 0.03 0.76 0.390 0.03 0.22 0.640 0.01 0.04 0.844 0.00 0.31 0.584 0.01 1.01 0.325 0.04 0.01 0.929 0.00
Sweaty 1.61 0.216 0.06 0.26 0.613 0.01 0.40 0.534 0.02 1.51 0.230 0.06 0.04 0.839 0.00 0.36 0.552 0.01 0.52 0.479 0.02
Headache 0.08 0.785 0.00 0.01 0.931 0.00 0.46 0.505 0.02 1.71 0.203 0.06 0.04 0.846 0.00 0.01 0.916 0.00 0.01 0.908 0.00
Excess Salivation 2.42 0.133 0.09 1.34 0.257 0.05 0.01 0.940 0.00 2.40 0.134 0.09 0.14 0.709 0.01 0.38 0.541 0.02 0.00 0.992 0.00
Heart Pounding 1.27 0.270 0.05 0.64 0.430 0.03 0.00 0.975 0.00 0.15 0.706 0.01 0.14 0.710 0.01 0.00 0.988 0.00 0.77 0.388 0.03
Confused 0.38 0.543 0.02 1.28 0.268 0.05 0.21 0.650 0.01 0.01 0.909 0.00 0.74 0.397 0.03 0.04 0.842 0.00 4.75 0.039 0.16
Weak 0.04 0.839 0.00 0.00 0.986 0.00 0.04 0.839 0.00 1.62 0.215 0.06 0.00 0.958 0.00 0.02 0.882 0.00 0.05 0.832 0.00
Direct Effects of Product Use
b
Satisfying 0.01 0.938 0.00 2.45 0.130 0.09 0.00 0.974 0.00 2.15 0.155 0.08 0.05 0.819 0.00 1.18 0.287 0.05 0.35 0.561 0.01
Pleasant 0.02 0.901 0.00 4.31 0.048 0.15 0.37 0.551 0.01 0.24 0.626 0.01 0.17 0.687 0.01 0.88 0.356 0.03 0.03 0.873 0.00
Taste Good 0.34 0.563 0.01 4.99 0.030 0.17 0.97 0.334 0.04 0.00 0.983 0.00 0.25 0.622 0.01 6.31 0.019 0.20 4.08 0.054 0.14
Dizzy 1.73 0.201 0.07 3.87 0.060 0.13 0.01 0.920 0.00 1.57 0.222 0.06 0.01 0.912 0.00 2.27 0.144 0.08 1.05 0.315 0.04
Calm 1.31 0.263 0.05 0.59 0.452 0.02 1.16 0.291 0.04 2.54 0.124 0.09 0.04 0.840 0.00 5.45 0.028 0.18 0.06 0.815 0.00
Concentrate 0.35 0.561 0.01 0.08 0.774 0.00 1.51 0.231 0.06 0.60 0.446 0.02 0.15 0.707 0.01 2.82 0.106 0.10 0.10 0.750 0.00
Awake 0.03 0.854 0.00 1.20 0.283 0.05 0.48 0.494 0.02 1.96 0.174 0.07 0.22 0.643 0.01 0.07 0.801 0.00 0.03 0.855 0.00
Reduced Hunger 0.05 0.827 0.00 0.80 0.381 0.03 0.00 0.960 0.00 0.00 0.970 0.00 0.37 0.550 0.01 2.93 0.099 0.11 0.08 0.783 0.00
Sick 1.78 0.194 0.07 0.66 0.426 0.03 0.94 0.342 0.04 0.14 0.715 0.01 2.40 0.134 0.09 0.98 0.333 0.04 1.60 0.218 0.06
gLMS
c
Sensation 0.20 0.660 0.02 0.17 0.685 0.01 0.08 0.789 0.01
Harshness 1.02 0.332 0.08 1.39 0.262 0.10 1.84 0.200 0.13
Throat Hit 0.36 0.561 0.03 4.09 0.066 0.26 0.38 0.547 0.03
Puff Duration
b
0.85 0.364 0.03 0.57 0.459 0.02 0.73 0.400 0.03
a
df = 1, 23; 
b
df = 1, 25; 
c
df = 1, 12
Flavor x Bout x 
Time
Flavor Bout Time Flavor x Bout Flavor x Time Bout x Time
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Mixed Repeated-Measure ANOVA Results by Race
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4 
Outcome Measure F p ηp
2
F p ηp
2
F p ηp
2
F p ηp
2
F p ηp
2
F p ηp
2
F p ηp
2
Physiological Measures
a
Heart Rate 0.53 0.474 0.02 0.04 0.850 0.00 1.58 0.220 0.06 0.76 0.374 0.55 1.80 0.190 0.07 11.05 0.003 0.30 11.20 0.002 0.30
Systolic 0.32 0.575 0.01 0.00 0.997 0.00 0.22 0.650 0.01 0.88 0.358 0.03 2.24 0.147 0.08 1.40 0.248 0.25 4.65 0.041 0.15
Diastolic 0.10 0.759 0.00 0.32 0.575 0.01 0.00 0.956 0.00 5.68 0.025 0.18 1.13 0.298 0.04 2.80 0.106 0.10 7.30 0.012 0.22
Direct Effects of Nicotine
b
Dizzy 0.32 0.579 0.01 3.70 0.065 0.12 6.25 0.019 0.18 0.29 0.595 0.01 2.22 0.147 0.07 0.67 0.420 0.02 0.00 0.961 0.00
Lightheaded 0.64 0.430 0.02 1.30 0.264 0.04 1.28 0.268 0.04 1.36 0.253 0.05 5.25 0.030 0.16 0.23 0.639 0.01 0.62 0.439 0.02
Nauseaus 0.06 0.808 0.00 3.79 0.062 0.12 0.50 0.486 0.02 5.67 0.024 0.17 1.18 0.288 0.04 0.07 0.801 0.00 1.20 0.284 0.04
Nervous 1.31 0.262 0.05 0.01 0.945 0.00 0.39 0.538 0.01 2.64 0.115 0.09 0.70 0.411 0.02 0.01 0.910 0.00 0.00 0.955 0.00
Sweaty 6.68 0.015 0.19 0.86 0.362 0.03 4.02 0.055 0.13 3.63 0.067 0.12 1.06 0.312 0.04 1.11 0.300 0.04 1.52 0.230 0.05
Headache 0.01 0.913 0.00 6.06 0.020 0.18 1.36 0.253 0.05 0.01 0.937 0.00 0.01 0.938 0.00 4.92 0.035 0.15 0.84 0.367 0.03
Excess Salivation 0.82 0.372 0.03 0.46 0.505 0.02 0.14 0.716 0.01 0.10 0.756 0.00 0.02 0.901 0.00 0.08 0.786 0.00 2.68 0.113 0.09
Heart Pounding 3.03 0.093 0.10 0.03 0.863 0.00 0.82 0.373 0.03 0.32 0.576 0.01 0.06 0.808 0.00 0.05 0.832 0.00 2.08 0.160 0.07
Confused 0.01 0.929 0.00 2.65 0.115 0.09 0.05 0.831 0.00 1.79 0.190 0.06 1.30 0.263 0.04 3.39 0.076 0.12 0.44 0.514 0.02
Weak 2.68 0.113 0.09 2.58 0.119 0.08 3.79 0.062 0.12 0.26 0.617 0.01 0.26 0.617 0.01 0.20 0.656 0.01 1.85 0.184 0.06
Direct Effects of Product Use
b
Satisfying 0.67 0.419 0.02 0.09 0.765 0.00 1.14 0.294 0.04 0.74 0.397 0.03 0.00 0.962 0.00 1.86 0.184 0.06 3.88 0.059 0.12
Pleasant 1.41 0.245 0.05 0.08 0.785 0.00 1.77 0.195 0.06 0.07 0.789 0.00 0.01 0.920 0.00 3.07 0.090 0.10 6.12 0.020 0.18
Taste Good 1.93 0.180 0.06 0.16 0.696 0.01 0.74 0.396 0.03 0.62 0.437 0.02 1.39 0.248 0.05 1.02 0.320 0.04 0.03 0.860 0.00
Dizzy 0.14 0.708 0.01 0.17 0.686 0.01 0.92 0.345 0.03 0.09 0.771 0.00 2.07 0.161 0.07 4.84 0.036 0.15 0.36 0.555 0.01
Calm 0.73 0.400 0.03 0.66 0.420 0.02 2.23 0.147 0.07 0.20 0.658 0.01 0.17 0.682 0.01 0.01 0.911 0.00 0.37 0.546 0.01
Concentrate 0.94 0.340 0.03 0.73 0.401 0.73 0.79 0.382 0.03 0.17 0.684 0.01 0.26 0.617 0.01 0.23 0.636 0.01 1.52 0.228 0.05
Awake 0.00 0.990 0.00 1.94 0.175 0.07 0.14 0.710 0.01 0.07 0.797 0.00 0.00 0.948 0.00 0.48 0.496 0.02 0.01 0.921 0.00
Reduced Hunger 0.68 0.420 0.02 2.08 0.160 0.07 0.71 0.406 0.03 0.42 0.520 0.02 0.22 0.645 0.01 0.04 0.845 0.00 0.04 0.843 0.00
Sick 0.03 0.864 0.00 7.47 0.011 0.21 1.49 0.232 0.05 0.16 0.695 0.01 0.00 0.953 0.00 0.32 0.574 0.01 0.65 0.428 0.02
gLMS
c
Sensation 0.53 0.480 0.03 4.73 0.046 0.24 0.83 0.377 0.05
Harshness 0.00 0.980 0.00 0.00 0.988 0.00 0.33 0.577 0.02
Throat Hit 0.68 0.424 0.04 1.70 0.212 0.10 0.51 0.484 0.03
Puff Duration
b
0.84 0.366 0.03 0.46 0.505 0.02 0.17 0.685 0.01
Flavor x Bout x Time 
x Race
a
df = 1, 26; 
b
df = 1, 28; 
c
df = 1, 15
Flavor x Race Bout x Race Time x Race
Flavor x Bout x 
Race
Flavor x Time x 
Race
Bout x Time x Race
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Repeated Measure ANOVA Results by Order 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5 
Outcome Measure F p ηp
2
F p ηp
2
F p ηp
2
F p ηp
2
F p ηp
2
F p ηp
2
F p ηp
2
Physiological Measures
a
Heart Rate 0.00 0.960 0.00 21.98 0.000 0.45 15.77 0.000 0.37 0.26 0.620 0.01 0.07 0.800 0.00 2.92 0.100 0.10 12.61 0.001 0.32
Systolic 1.84 0.190 0.06 0.34 0.570 0.01 10.47 0.003 0.28 0.01 0.920 0.00 0.69 0.420 0.03 0.05 0.830 0.00 1.22 0.280 0.04
Diastolic 1.23 0.280 0.04 0.55 0.470 0.02 6.41 0.020 0.19 0.60 0.450 0.02 0.04 0.840 0.00 0.07 0.800 0.00 2.96 0.100 0.10
Direct Effects of Nicotine
b
Dizzy 7.47 0.010 0.21 2.03 0.170 0.07 19.99 0.000 0.41 0.34 0.570 0.01 0.27 0.610 0.01 3.49 0.070 0.12 3.17 0.090 0.10
Lightheaded 12.44 0.001 0.30 5.61 0.030 0.16 33.09 0.000 0.53 0.01 0.910 0.00 0.48 0.490 0.02 2.01 0.170 0.07 3.73 0.060 0.11
Nauseaus 7.18 0.010 0.20 0.03 0.860 0.00 14.18 0.001 0.33 0.00 0.950 0.00 0.51 0.480 0.02 0.05 0.820 0.00 1.65 0.210 0.05
Nervous 0.83 0.370 0.03 6.96 0.010 0.19 0.59 0.450 0.02 0.04 0.840 0.00 0.30 0.590 0.01 2.69 0.110 0.09 0.74 0.400 0.03
Sweaty 0.07 0.800 0.00 2.04 0.160 0.07 0.43 0.520 0.02 0.33 0.570 0.01 0.22 0.650 0.01 5.92 0.020 0.17 0.35 0.560 0.01
Headache 0.87 0.360 0.03 3.20 0.080 0.10 3.06 0.090 0.10 0.08 0.790 0.00 0.28 0.600 0.01 0.06 0.810 0.00 0.19 0.670 0.01
Excess Salivation 2.88 0.100 0.09 1.09 0.300 0.04 2.19 0.150 0.07 0.60 0.450 0.02 3.86 0.060 0.12 0.32 0.580 0.01 0.29 0.590 0.01
Heart Pounding 0.11 0.750 0.00 4.35 0.046 0.13 2.67 0.110 0.08 0.15 0.710 0.01 0.02 0.900 0.00 1.98 0.170 0.06 0.04 0.840 0.00
Confused 3.29 0.080 0.10 0.05 0.810 0.00 2.19 0.150 0.07 0.63 0.430 0.02 0.68 0.420 0.02 0.25 0.620 0.01 0.16 0.690 0.01
Weak 4.70 0.040 0.14 0.10 0.760 0.00 4.51 0.040 0.14 1.77 0.190 0.06 1.00 0.320 0.03 2.23 0.150 0.07 3.13 0.090 0.10
Direct Effects of Product Use
b
Satisfying 0.10 0.760 0.00 18.08 0.000 0.38 44.97 0.000 0.61 0.00 0.950 0.00 0.44 0.520 0.02 15.62 0.000 0.35 0.00 0.950 0.00
Pleasant 0.77 0.390 0.03 23.08 0.000 0.44 36.36 0.000 0.56 0.51 0.480 0.02 0.05 0.830 0.00 12.73 0.001 0.31 0.35 0.560 0.01
Taste Good 3.81 0.060 0.12 18.89 0.000 0.39 41.40 0.000 0.59 0.11 0.740 0.00 3.72 0.060 0.11 23.96 0.000 0.45 0.72 0.400 0.02
Dizzy 3.72 0.060 0.11 20.81 0.000 0.42 37.50 0.000 0.56 2.03 0.170 0.07 0.07 0.800 0.00 13.67 0.001 0.32 2.59 0.120 0.08
Calm 9.60 0.004 0.25 11.38 0.002 0.28 23.50 0.000 0.45 1.17 0.290 0.04 7.41 0.010 0.20 17.17 0.000 0.37 1.04 0.320 0.03
Concentrate 0.12 0.730 0.00 9.38 0.010 0.24 15.32 0.001 0.35 0.01 0.920 0.00 0.01 0.940 0.00 3.25 0.080 0.10 0.04 0.840 0.00
Awake 1.17 0.290 0.04 8.60 0.010 0.23 26.15 0.000 0.47 0.83 0.370 0.03 3.20 0.080 0.10 8.56 0.010 0.23 0.10 0.750 0.00
Reduced Hunger 5.40 0.030 0.16 9.20 0.010 0.24 35.74 0.000 0.55 0.06 0.810 0.00 2.83 0.100 0.09 16.03 0.000 0.36 2.12 0.160 0.07
Sick 5.49 0.030 0.16 5.74 0.020 0.17 13.00 0.001 0.31 0.77 0.390 0.03 11.37 0.002 0.28 13.99 0.001 0.33 3.34 0.080 0.10
gLMS
c
Sensation 0.00 0.970 0.00 1.86 0.190 0.10 0.77 0.390 0.05
Harshness 0.07 0.790 0.01 2.75 0.120 0.15 0.50 0.490 0.03
Throat Hit 0.00 1.000 0.00 0.91 0.350 0.05 0.01 0.920 0.00
Puff Duration
b
0.04 0.850 0.00 11.27 0.002 0.28 3.92 0.060 0.12
a
df = 1, 27; 
b
df = 1, 29; 
c
df = 1, 16
Order x Bout x TimeOrder Bout Time Order x Bout Order x Time Bout x Time
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Mixed Repeated measure ANOVAs for Behavioral Economics Outcomes
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 6 
Outcome Measure F p ηp
2
F p ηp
2
PRT
a
Breakpoint 0.14 0.712 0.01 0.38 0.542 0.01
Rewards earned 1.49 0.233 0.05 3.84 0.060 0.12
Total responses 0.04 0.852 0.00 0.19 0.665 0.01
Responses per minute 0.09 0.766 0.00 0.29 0.594 0.01
Latency to puff
b
0.19 0.670 0.02 0.58 0.462 0.05
PBPT
a
Breakpoint
c
0.01 0.928 0.00 0.02 0.889 0.00
Intensity 0.27 0.609 0.01 0.00 0.990 0.00
AUC 0.01 0.918 0.00 0.04 0.850 0.00
Elasticity 0.13 0.720 0.01 0.10 0.757 0.00
a
df = 1, 28; 
b
df = 1, 11; 
c
df = 1, 26
Flavor Flavor x Race
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Means and Standard Deviations  for Behavioral Economics Outcomes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 7 
Fruit Tobacco
Rewards Earned 3.48 (5.67) 3.52 (6.08)
Breakpoint 112.83 (248.22) 136.20 (298.42)
Total responses 395.6 (1004.92) 439.57 (1063.98)
Responses per minute 19.78 (50.25) 22.93 (53.13)
Latency to puff 3.98 (1.00) 3.75 (1.00)
Breakpoint 68.93 (77.98) 75.11 (83.98)
Demand Intensity 62.83 (41.48) 66.67 (36.14)
Demand elasticity 0.0004 (.002) .001 (.007)
AUC 0.06 (.08) .06 (.06)
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Means and Standard Deviations for ECIG Outcome Expectancies 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
M (SD)
Positive Score 11.83 (7.04)
Become more popular 2.33 (2.45)
Feel relaxed 3.03 (2.53)
Enjoy "smoking" without bothering others 3.73 (2.75)
Smell Good 2.73 (2.46)
Negative Score 21.7 (4.35)
Hurt Lungs 6.97 (2.08)
Look Awkward 3.37 (2.59)
Become Addicted 6.67 (2.37)
Bad Taste 4.7 (2.34)
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Table 8 
Frequencies Flavor Preferences from Participant Exit Interviews 
Flavors Prefer Dislike
Mint/menthol 10 9
Tobacco 0 8
Mango 7 0
Berry/berry medley 5 3
Crème brulee 2 1
Cereal/Drink 4 1
Other 4 5
None 6 10
N/A (did not remember) 2 1  
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Table 9 
Themes and Response Summaries from Participant Exit Interviews 
Reasons for liking flavors Reasons for disliking flavors Settings for product use Reasons for product use
Enjoys the taste of fruity flavors. "Tobacco was pretty gross, 
because it tasted like an ash tray"
Hanging out with friends, driving, 
parties, anywhere during social 
interaction
Just because someone offered. Said no for 
a while, but finally gave in. After that, just 
used when people offered. 
Likes pink lemonade because it 
tastes just like the drink. 
Didn’t hate any, but if they had to 
pick one they wouldn’t pick the 
tobacco flavor because it doesn’t 
have much of a taste.  
Driving in a car, at the beach, 
outside, on campus
First time using, saw that friends had used 
them and was curious. Liked it, and used it 
other times when friends have them out.
Prefers raspberry because it 
tastes sweeter than other flavors.
Thought that mint tasted too harsh. At a party or with friends at one of 
their houses
It was just what everyone was doing, 
decided to try it "to better fit in"
Prefers cucumber because it 
tasted very clean. Also liked 
crème brulee and mango 
because those two did not hurt 
and were not accompanied by 
burn from the ECIG. 
Virginia tobacco and tobacco are 
sickness-inducing and lead to 
feeling lightheaded, clammy, and 
like they are about to pass out. 
Can make their stomach feel upset. 
At a party, at home, in the car driving 
around, a concert, usually with 
people. Doesn’t enjoy doing it by 
themselves. Feel more social than it 
is relaxing. 
Just to taste different flavors. Usually 
someone asks if I want to try a different 
flavor, I never seek it out. 
Disliked mint flavor because it 
burned.
Only at parties when alcohol is 
involved
First few times they liked getting a buzz and 
wanted to try to make smoke rings. With 
ECIGS they mostly enjoy the buzz and the 
taste. When other people are using an 
ECIG, it makes them want to do it. 
Didn’t like crème brulee because 
they don't like caramel. Hot tamale 
was too strong. Mint tasted like a 
throat hit. Too harsh. 
Drunk, usually at a bar or at the lake. Pressure from roommates who said it 
wasn’t that bad. They decided to try it 
again in different flavors, because they were 
told that they did it wrong the first time. 
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Figure 1. Session procedure.  
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Figure 2. Mean (+/- SEMs) ratings are shown for the DEPS item “dizzy” for bout x time x race 
effects as a function of flavor (fruit vs. tobacco) x bout (1 vs. 2) x  time (pre vs. post) for White 
and non-White participants. Filled symbols = significant differences pre- to post- within bout; 
+ = significant differences between race groups for fruit flavor within timepoint; ++ = 
significant differences between race groups for tobacco flavor within timepoint. 
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Figure 3. Mean (+/- SEMs) ratings are shown for the DEPS item “pleasant” for flavor x bout x 
time x race effects as a function of flavor (fruit vs. tobacco) x bout (1 vs. 2) x  time (pre vs. 
post) for White and non-White participants. Filled symbols = significant differences pre- to 
post- within bout; + = significant differences between race groups for fruit flavor within 
timepoint; ++ = significant differences between race groups for tobacco flavor within 
timepoint. 
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Figure 4. Fruit flavor demand curve for probability-based purchase task. Probability of purchase 
across a range of prices is depicted for all participants in the fruit flavor condition. Dashed line 
represents average demand curve.  
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Figure 5. Tobacco flavor demand curve for probability-based purchase task. Probability of 
purchase across a range of prices is depicted for all participants in the tobacco flavor  condition. 
Dashed line represents average demand curve.  
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Figure 6. Mean (+/- SEMs) ratings are shown for the DENS item “confused” for flavor x bout x 
time effects as a function of flavor (fruit vs. tobacco) x bout (1 vs. 2) x  time (pre vs. post). 
Filled symbols = significant differences pre- to post- within bout. 
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Figure 7. Mean (+/- SEMs) ratings are shown for the DENS item “nauseous” for flavor x 
bout x race effects as a function of flavor (fruit vs. tobacco) x bout (1 vs. 2) x  time (pre vs. 
post) for White and non-White participants. Filled symbols = significant differences between 
bouts; + = significant differences between race groups for fruit flavor within bout; ++ = 
significant differences between race groups for tobacco flavor within bout. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FLAVORS IN ECIG ABUSE LIABILITY IN NON-TOBACCO YOUTH 
 
 
87 
 
Figure 8. Mean (+/- SEMs) ratings are shown for the DENS item “lightheaded” for flavor x 
time x race effects as a function of flavor (fruit vs. tobacco) x bout (1 vs. 2) x  time (pre vs. 
post) for White and non-White participants. Filled symbols = significant differences pre- to 
post- within bout; + = significant differences between race groups for fruit flavor within 
timepoint; ++ = significant differences between race groups for tobacco flavor within 
timepoint. 
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Figure 9. Mean (+/- SEMs) ratings are shown for the DENS item “headache”  for bout x time x 
race effects as a function of flavor (fruit vs. tobacco) x bout (1 vs. 2) x  time (pre vs. post) for 
White and non-White participants. Filled symbols = significant differences pre- to post- within 
bout; + = significant differences between race groups for fruit flavor within timepoint; ++ = 
significant differences between race groups for tobacco flavor within timepoint. 
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Figure 10. Mean (+/- SEMs) ratings are shown for diastolic blood pressure for flavor x bout x 
race effects as a function of flavor (fruit vs. tobacco) x bout (1 vs. 2) x  time (pre vs. post) for 
White and non-White participants. Filled symbols = significant differences between bouts; + 
= significant differences between race groups for fruit flavor within bout; ++ = significant 
differences between race groups for tobacco flavor within bout. 
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Figure 11. Mean (+/- SEMs) ratings are shown for heart rate for bout x time x race effects as a 
function of flavor (fruit vs. tobacco) x bout (1 vs. 2) x  time (pre vs. post) for White and non-
White participants. Filled symbols = significant differences pre- to post- within bout; + = 
significant differences between race groups for fruit flavor within timepoint; ++ = significant 
differences between race groups for tobacco flavor within timepoint. 
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Figure 12. Mean (+/- SEMs) ratings are shown for heart rate for flavor x bout x time x race 
effects as a function of flavor (fruit vs. tobacco) x bout (1 vs. 2) x  time (pre vs. post) for 
White and non-White participants. Filled symbols = significant differences pre- to post- 
within bout; + = significant differences between race groups for fruit flavor within timepoint; 
++ = significant differences between race groups for tobacco flavor within timepoint. 
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Figure 13. Mean (+/- SEMs) ratings are shown for systolic blood pressure for flavor x bout x 
time x race effects as a function of flavor (fruit vs. tobacco) x bout (1 vs. 2) x  time (pre vs. 
post) for White and non-White participants. Filled symbols = significant differences pre- to 
post- within bout; + = significant differences between race groups for fruit flavor within 
timepoint; ++ = significant differences between race groups for tobacco flavor within 
timepoint. 
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Figure 14. Mean (+/- SEMs) ratings are shown for diastolic blood pressure for flavor x bout 
x time x race as a function of flavor (fruit vs. tobacco) x bout (1 vs. 2) x  time (pre vs. post) 
for White and non-White participants. Filled symbols = significant differences pre- to post- 
within bout; + = significant differences between race groups for fruit flavor within timepoint; 
++ = significant differences between race groups for tobacco flavor within timepoint or bout. 
FLAVORS IN ECIG ABUSE LIABILITY IN NON-TOBACCO YOUTH 
 
 
94 
 
 
Figure 15. Mean (+/- SEMs) ratings are shown for heart rate for order x bout x time effects as a 
function of flavor (fruit vs. tobacco) x bout (1 vs. 2) x  time (pre vs. post) for session 1 and 
session 2. Filled symbols = significant differences pre- to post- within bout; + = significant 
differences between sessions. 
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Appendix A  
Telephone Screening Questionnaire 
 
Date: _______________     Interviewer: _______________ 
 
Interviewer:  “I would like to ask you some questions about yourself and your health status as 
well as your use of tobacco, alcohol, and other drugs. The purpose of these questions is to 
determine whether or not you are eligible to participate in the study that I just described to you.  
All of your responses are confidential.  You are not required to answer any question and you may 
stop this interview at any time. May I begin the questions?” 
 
Document caller’s response by circling either:    Yes      or      No 
 
If Yes: begin form.  If No: thank the caller and stop the interview. 
--------------------------------------------------------------------------------------------------------------------- 
How did you hear about us/our study?    ________________________ 
Personal Information: 
1.  “What is your first name?”      ________________________ 
2.  “What is a phone number at which you can be contacted?”  ________________________ 
3.  “If we call and you are not available, may we leave a message?”   Yes      or      No 
4.  “What is your date of birth?”      ________________________  
 
General health status: 
1.  “Are you currently under a doctor’s care for a medical condition?” Yes      or      No 
If Yes: “Please describe the concern or problem”: 
2.  “Do you have any chronic health concerns or problems?”   Yes      or      No 
  If Yes: “Please describe the condition”: 
3.  “Are you taking any prescription or over-the-counter medications?” Yes      or      No 
If Yes: “Please identify the medication”: 
4.  Do you have any psychiatric conditions like depression or anxiety?  Yes      or      No 
If Yes: “Please describe the condition”: 
5.  “Have you ever been diagnosed with high or low blood pressure?”  Yes      or      No 
  If Yes: “Please indicate whether it is high or low”: 
For women only: 
6.  “Are you currently pregnant?”      Yes      or      No 
7.  “Are you currently breast-feeding a child?”    Yes      or      No 
--------------------------------------------------------------------------------------------------------------------- 
Tobacco Use: 
1.  “Do you currently smoke tobacco cigarettes?”    Yes      or      No 
2.  “Have you ever smoked a tobacco cigarette?”               Yes      or      No 
 a) If yes, how many lifetime uses?                                              ____________________ 
           
Electronic Cigarette Use: 
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1.  “Do you currently use an electronic cigarette?”    Yes      or      No 
2.  “Have you ever used an electronic cigarette in your lifetime, 
 even one puff??”                   Yes      or      No 
a) If yes, about how many times have you used one in your lifetime?        ___________________   
                  
3.  “Do you remember what nicotine concentration of liquid you used?” ___________(mg/ml) 
4.  “Do you remember what flavor of liquid you used?”         ____________________ 
5.  “Do you remember what brand of liquid you used?”         ____________________ 
 
Other Tobacco Use: 
1.  “Have you used any of the following other nicotine/tobacco products?”   
 
 EVER EVER 
If ‘yes’, estimate how many days 
you have used this product in the 
past month, if any? 
Large cigars No Yes  
Cigarillos (e.g., Black & Milds) 
or small cigars 
No Yes  
Waterpipe (a.k.a. hookah or 
shisha) 
No Yes  
Smokeless tobacco 
(snuff/dip/chew/snus) 
No Yes  
Electronic Cigarette (if cigarette 
smoker) 
No Yes  
Other: _______________ No Yes 
 
 
 
-------------------------------------------------------------------------------------------------------------------- 
Illicit Drug Use: 
 
1. “Have you used any of the following other drugs for recreational purposes in the past 
month?” 
   If ‘yes’, estimate how 
many days you have used 
this product in the past 
month? 
Alcohol No Yes 
 
Marijuana / Spice / K2 No Yes  
Stimulants (e.g., cocaine, amphetamine, 
etc.) 
No Yes 
 
Opiates (e.g., heroin, oxycodone, etc.) 
No Yes 
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Other: No Yes 
 
 
 
Interviewer:  “Thank you for responding to these questions.  I need to pass on your responses to 
the principal investigator who will then determine whether or not you are eligible to participate 
in a study.  If you are eligible, someone will contact you within approximately one week. If you 
are not eligible for this study, then you will not be contacted.” 
 [If respondent does not have a phone, they can call us back in a few days] 
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Appendix B 
 
Demographic Information 
______________________________________________________________________________  
 
Participant ID: ______________    Today’s Date: _____________ 
 
 
Age  
 
Years: __________    Date of birth: _____________________  
______________________________________________________________________________  
 
Ethnicity  
 
o Hispanic or Latino    o Not Hispanic or Latino  
______________________________________________________________________________  
 
Race  
 
o American Indian/Alaskan Native  o Asian/Native Hawaiian or other Pacific Islander  
 
o Black or African American  o White   o Other/Unknown  
______________________________________________________________________________  
 
Gender  
 
o Male      o Female  
______________________________________________________________________________  
 
Marital status  
 
o Single  o Married  o Separated  o Divorced  o Widowed  
______________________________________________________________________________  
 
Education  
 
Years: __________ (For example, High school = 12, College degree = 16, etc.)  
______________________________________________________________________________  
 
Primary employment  
 
o Unemployed    o Part Time (0-30 hrs/wk)    o Full Time (>30 hrs/wk)  o Student  
______________________________________________________________________________ 
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Appendix C 
 
Medical History and Drug Use Form 
 
 Participant ID: ___________      Date: ______________ 
 
 General health status:  
 
Are you under a doctor’s care for a medical condition?____________ (If yes, please describe 
below)  
 
Are you taking any prescription medications?       ________ (If yes, please identify below)  
 
Do you have any chronic health concerns or problems?  ________ (If yes, please describe below)  
 
Do you have any psychiatric conditions?        ________ (If yes, please describe below) 
 
For women only:  
 
Are you currently pregnant?   _______ (yes or no)  
 
Are you currently breast-feeding a child? ______ (yes or no)  
 
Cigarette Use:  
 
Have you ever smoked tobacco cigarettes? ____________  ( if yes, number of lifetime uses)  
 
Do you currently smoke tobacco cigarettes? ________ (yes or no) if no, skip to the next section  
 
ECIG Use: 
 
Do you currently use an ECIG?  ________(yes or no)  
 
Have you ever used an ECIG, even one puff? ______(yes or no) if no skip to next section 
 
a) About how many times have you used an ECIG in your lifetime? _______________ 
b) Do you remember what nicotine level you used?        _______________(mg/ml or %) 
c) Do you remember what flavor of ECIG you used?                         _______________ 
 
Other Tobacco Use:  
 
Have you ever used any other nicotine/tobacco products? ____________ (yes or no)  
 
Circle all products below that you have ever used, for each item used please indicate # of lifetime 
uses:  
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Cigars / cigarillos / small cigars ______(#uses)   
 
Smokeless tobacco (snuff, dip, chew) / snus ______(#uses)   
 
Hookah / waterpipe ______(#uses)   
 
Electronic cigarette ______(#uses)   
 
Nicotine gum / patch / lozenge / inhaler ______(#uses)    
 
Other: ________________________ 
 
--------------------------------------------------------------------------------------------------------------------- 
 
Do you currently use any other nicotine/tobacco products? ____________ (yes or no)  
 
Circle all products below that you have used in the past 30 days:  
 
Cigars / cigarillos / small cigars   Smokeless tobacco (snuff, dip, chew) / snus 
 
Hookah / waterpipe     Electronic cigarette 
 
Nicotine gum / patch / lozenge / inhaler  Other: ________________________ 
 
 
Alcohol Use:  
 
Have you used alcohol in the past month? ________ (yes or no) if no, skip to the next section  
 
How many days out of the last 30 have you used alcohol? __________________ (number of 
days)  
 
Have you ever been treated for alcohol abuse/dependence? __________________ (yes or no)  
 
Other Drug Use:  
 
Have you used any illegal drugs within the past month? ________ (yes or no)  
If yes, please identify which drugs: ______________________________________ 
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Appendix D 
Electronic Cigarette Outcome Expectancy Short Scale 
 
The following scale includes statements about outcomes that might happen to you if you used e-
cigarettes. Please rate how LIKELY or UNLIKELY you believe each outcome would be for you if 
you used e-cigarettes. For example, if you believe that e-cigarette use would definitely make you 
“feel good,” circle 9. If you believe that e-cigarette use would never make you “feel good,” 
circle 0. And if you believe e-cigarette use would only slightly decrease or increase your chance 
of feeling good, circle 4 or 5. 
 
What is the likelihood that the following outcomes would happen to you if you used e-cigarettes? 
(Response Options: 0:Unlikely,…, 9:Likely) 
 
 
 
Become more popular 
 
0  1  2  3  4  5  6  7  8  9  
  
Feel relaxed  
 
0  1  2  3  4  5  6  7  8  9 
 
Hurt lungs 
 
0  1  2  3  4  5  6  7  8  9 
 
Enjoy “smoking” without bothering others 
 
 0  1  2  3  4  5  6  7  8  9   
 
Look awkward 
 0  1  2  3  4  5  6  7  8  9   
 
Become addicted to e-cigarettes 
 
 0  1  2  3  4  5  6  7  8  9   
 
Feel bad taste 
 
 0  1  2  3  4  5  6  7  8  9   
 
Smell good 
 
 0  1  2  3  4  5  6  7  8  9   
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Appendix E 
ECIG Risk Perception 
 
Please indicate the degree to which you agree or disagree with the following statements regarding 
electronic cigarettes.  
______________________________________________________________________________ 
 
Electronic cigarettes are less harmful than regular cigarettes.  
 
o Strongly disagree  o Disagree  o Agree  o Strongly Agree  
______________________________________________________________________________  
 
Electronic cigarettes can help people quit smoking.  
 
o Strongly disagree  o Disagree  o Agree  o Strongly Agree  
______________________________________________________________________________  
 
Electronic cigarettes are less addictive than cigarettes.  
 
o Strongly disagree  o Disagree  o Agree  o Strongly Agree  
______________________________________________________________________________  
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Appendix F 
Exit Interview 
 
ECIG Use History: For the next 9 questions, I’d like for you to think about the times in 
your life when you used an ECIG. 
1. Did the ECIGs that you used contain nicotine never, sometimes or always? 
 
2. Do you remember the amount(s) of nicotine that those ECIGs contained? [Participants can 
provide more than one nicotine concentration level if they believe that those previous devices 
had different concentrations] 
 
3. Do you remember what flavor(s) of liquid you used in those ECIGs? List all flavors 
used/tried. 
 
4. Of those flavors that you used, did you have any that you liked the most? 
 
5. Of those flavors that you used, did you have any that you disliked? 
 
6. Do you remember what type and/or brand of ECIG device you used? Please list all that apply 
and provide as many details as possible. 
 
7. Where did you obtain the ECIG(s) you used? For example, did you get it from a friend, a 
family member, or a stranger? Did you get any free samples or purchase an ECIG? List all 
that apply. 
 
8. Do you remember where you were / what you were doing when you used the ECIG(s)? For 
example, were you at home, hanging out with friends, at a party/bar? List all that apply. 
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9. What were some reasons why you decided to use an ECIG? [Here you can prompt them to 
give reasons for the first time specifically, and then any of the other times] 
 
Study Experience: For the next 4 questions, we’d like to ask you to share your feelings 
about the experience of participating in this study. 
1. I’d like for you to think about the ECIG device and liquid that you used in this study. We 
are interested in your thoughts about the experience with that particular device and liquid. 
[Here we want to make sure to touch upon the following factors: a) nicotine concentration, 
b) flavor, c) device type, d) amount of ECIG liquid consumed within a session] 
 
2. For what reason(s) did you decide to take part in this study? 
 
3. What aspects of the study did you like or dislike in particular? 
 
4.   Looking back, was the study what you expected or not? In what way was the study different 
from what you expected? How do you feel about that? 
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Appendix G 
Direct Effects of Nicotine Scale 
 
 
 
 
 
 
 
 
1. Nauseous 
 
 
2. Dizzy 
 
 
3. Lightheaded 
 
 
4. Nervous 
 
 
5. Sweaty 
 
 
6. Headache 
 
 
7. Excessive salivation 
 
 
8. Heart pounding 
 
 
9. Confused  
 
 
10. Weak 
 
  
These phrases may or may not describe how you feel right now.  Please respond to 
each word or phrase with how you feel RIGHT NOW by drawing a vertical mark 
anywhere along the horizontal line. 
Not at all Extremely 
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Appendix H 
Direct Effects of ECIG USE 
 
 
 
 
 
 
 
 
 
 
1. Was the product satisfying? 
 
 
2.  Was the product pleasant?  
 
 
3.  Did the product taste good?  
 
 
4.  Did the product make you dizzy? 
 
 
5.  Did the product calm you down? 
 
 
6.  Did the product help you concentrate? 
 
 
7.  Did the product make you feel more awake? 
 
 
8.  Did the product reduce your hunger for food? 
 
 
9. Did the product make you sick? 
 
 
 
 
 
 
 
 
 
These phrases may or may not describe how you feel right now.  Please respond to 
each word or phrase with how you feel RIGHT NOW by drawing a vertical mark 
anywhere along the horizontal line. 
Not at all Extremely 
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Appendix I 
For each item, please indicate how you would describe the 
ECIG you just used by placing a mark on the vertical numbered 
line.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Strongest Imaginable 
Sensation of Any 
Kind 
Very Strong 
Strong 
Moderate 
Weak 
Barely Detectable   
No Sensation 
How would you describe 
the overall flavor sensation 
of the ECIG you just used? 
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How would you describe 
the overall 
harshness/irritancy of the 
ECIG you just used? 
Strongest Imaginable 
Sensation of Any 
Kind 
Very Strong 
Strong 
Moderate 
Barely Detectable   
No Sensation 
Weak 
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How would you describe 
the throat hit of the ECIG 
you just used? 
Strongest Imaginable 
Sensation of Any 
Kind 
Very Strong 
Strong 
Moderate 
Barely Detectable   
No Sensation 
Weak 
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Appendix J 
End-of-Study Flavor Choice (Mango) 
 
Date: ____________      Participant ID: ____________ 
 
In this study, you used two different flavors of JUUL. During one visit, you used a JUUL 
that was flavored with tobacco. During another visit, you used a JUUL that was flavored 
with mango. For each flavor option below, circle which visit you think you used that flavor 
that is listed 
 
I used TOBACCO in  I used MANGO in 
 
Visit 1 
 
Visit 2 
  
Visit 1 
 
Visit 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FLAVORS IN ECIG ABUSE LIABILITY IN NON-TOBACCO YOUTH 
 
 
111 
 
End-of-Study Flavor Choice (Fruit Medley) 
 
Date: ____________      Participant ID: ____________ 
 
In this study, you used two different flavors of JUUL. During one visit, you used a JUUL 
that was flavored with tobacco. During another visit, you used a JUUL that was flavored 
with fruit medley. For each flavor option below, circle which visit you think you used that 
flavor that is listed 
 
I used TOBACCO in  I used FRUIT MEDLEY in 
 
Visit 1 
 
Visit 2 
  
Visit 1 
 
Visit 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
